|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.01698451
|
|
|
VRNI
|
[NCBI]
|
0.01098672
|
|
|
PSORS2
|
[NCBI]
|
0.00747276
|
|
|
MAFD1
|
[NCBI]
|
0.00738636
|
|
|
MAFD6
|
[NCBI]
|
0.00710934
|
|
|
autism
|
[NCBI]
|
0.00610534
|
|
|
HPCX
|
[NCBI]
|
0.00574726
|
|
|
SCZD7
|
[NCBI]
|
0.00516326
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.0047393
|
|
|
PSORS4
|
[NCBI]
|
0.00460209
|
|
|
CF
|
[NCBI]
|
0.00435387
|
|
|
IDDM
|
[NCBI]
|
0.00416914
|
|
|
IBD5
|
[NCBI]
|
0.00409633
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.00405982
|
|
|
APOE
|
[NCBI]
|
0.00395327
|
|
|
HPC10
|
[NCBI]
|
0.00372948
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.00371612
|
|
|
CELIAC6
|
[NCBI]
|
0.00371612
|
|
|
IDDM4
|
[NCBI]
|
0.00365149
|
|
|
AUTS5
|
[NCBI]
|
0.00325252
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.00323721
|
|
|
AUTS6
|
[NCBI]
|
0.00287195
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.00286925
|
|
|
IBD3
|
[NCBI]
|
0.00286925
|
|
|
HSCR9
|
[NCBI]
|
0.00278624
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.00278624
|
|
|
PSORS3
|
[NCBI]
|
0.00278624
|
|
|
IDDM3
|
[NCBI]
|
0.00278624
|
|
|
PARK10
|
[NCBI]
|
0.00278624
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00278624
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.00278624
|
|
|
IDDM18
|
[NCBI]
|
0.00278624
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.00278624
|
|
|
PSORS5
|
[NCBI]
|
0.00278624
|
|
|
IDDM13
|
[NCBI]
|
0.00278624
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.00278624
|
|
|
CRCS2
|
[NCBI]
|
0.00278624
|
|
|
CHDS8
|
[NCBI]
|
0.00278624
|
|
|
IBD6
|
[NCBI]
|
0.00278624
|
|
|
IDDM15
|
[NCBI]
|
0.00278624
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.00274932
|
|
|
IBD2
|
[NCBI]
|
0.00272211
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.00243539
|
|
|
SCZD
|
[NCBI]
|
0.00232896
|
|
|
prostate cancer
|
[NCBI]
|
0.00228976
|
|
|
IBD1
|
[NCBI]
|
0.00223059
|
|
|
MBL2
|
[NCBI]
|
0.002138021
|
|
|
ANON1
|
[NCBI]
|
0.002135318
|
|
|
IS1
|
[NCBI]
|
0.002111315
|
|
|
SCZD6
|
[NCBI]
|
0.002028442
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.002027484
|
|
|
parkinson disease 12
|
[NCBI]
|
0.002027484
|
|
|
SLEB3
|
[NCBI]
|
0.002027484
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.002027484
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.002027484
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.001884153
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.001884153
|
|
|
myopia 9
|
[NCBI]
|
0.001856929
|
|
|
myopia 7
|
[NCBI]
|
0.001856929
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.001856929
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.001856929
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.001856929
|
|
|
AIS3
|
[NCBI]
|
0.001856929
|
|
|
SLI2
|
[NCBI]
|
0.001856929
|
|
|
myopia 8
|
[NCBI]
|
0.001856929
|
|
|
SLI1
|
[NCBI]
|
0.001856929
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.001856929
|
|
|
MAFD4
|
[NCBI]
|
0.001856929
|
|
|
PEE2
|
[NCBI]
|
0.001856929
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.001856929
|
|
|
myopia 14
|
[NCBI]
|
0.001856929
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.001856929
|
|
|
IBD4
|
[NCBI]
|
0.001856929
|
|
|
AIS2
|
[NCBI]
|
0.001856929
|
|
|
IDDM8
|
[NCBI]
|
0.001856929
|
|
|
IDDM6
|
[NCBI]
|
0.001856929
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.001856929
|
|
|
myopia 10
|
[NCBI]
|
0.001856929
|
|
|
ATOD2
|
[NCBI]
|
0.001856929
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.001856929
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.001849316
|
|
|
COMT
|
[NCBI]
|
0.001844073
|
|
|
PEE1
|
[NCBI]
|
0.001781472
|
|
|
PSORS1
|
[NCBI]
|
0.001703793
|
|
|
BULN1
|
[NCBI]
|
0.001687624
|
|
|
VDR
|
[NCBI]
|
0.001675789
|
|
|
CELIAC2
|
[NCBI]
|
0.001663838
|
|
|
CELIAC5
|
[NCBI]
|
0.001566843
|
|
|
CD
|
[NCBI]
|
0.001534063
|
|
|
IDDM17
|
[NCBI]
|
0.001506732
|
|
|
AUTS7
|
[NCBI]
|
0.001506732
|
|
|
AUTS9
|
[NCBI]
|
0.0015057
|
|
|
SCZD3
|
[NCBI]
|
0.001491456
|
|
|
CRC
|
[NCBI]
|
0.001474363
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.00145141
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.001379382
|
|
|
SCZD5
|
[NCBI]
|
0.001356745
|
|
|
MS
|
[NCBI]
|
0.001269886
|
|
|
EGF
|
[NCBI]
|
0.001240613
|
|
|
IDDM7
|
[NCBI]
|
0.001225723
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
0.00122012
|
|
|
mutagen sensitivity
|
[NCBI]
|
0.001216646
|
|
|
ALSFTD2
|
[NCBI]
|
0.001216646
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.001216646
|
|
|
myopia 6
|
[NCBI]
|
0.001216646
|
|
|
IBD9
|
[NCBI]
|
0.001216646
|
|
|
SLC11A1
|
[NCBI]
|
0.001161748
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.001146353
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
0.001085896
|
|
|
PTH
|
[NCBI]
|
0.001073326
|
|
|
asperger syndrome, susceptibility to, 1
|
[NCBI]
|
0.001066659
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.001060308
|
|
|
CEACAM5
|
[NCBI]
|
0.001021631
|
|
|
PRL
|
[NCBI]
|
0.001008292
|
|
|
CFH
|
[NCBI]
|
0.001004351
|
|
|
BRCA1
|
[NCBI]
|
0.000989219
|
|
|
IGAN1
|
[NCBI]
|
0.000974401
|
|
|
HMPS1
|
[NCBI]
|
0.000941108
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000941108
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000941108
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000941108
|
|
|
LTA
|
[NCBI]
|
0.000940026
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000928182
|
|
|
ATOD3
|
[NCBI]
|
0.000928182
|
|
|
li-fraumeni syndrome 3
|
[NCBI]
|
0.000928182
|
|
|
leukemia, chronic lymphocytic, susceptibility to, 1
|
[NCBI]
|
0.000928182
|
|
|
FMTLE
|
[NCBI]
|
0.000928182
|
|
|
panic disorder 2
|
[NCBI]
|
0.000928182
|
|
|
PPR3
|
[NCBI]
|
0.000928182
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000928182
|
|
|
IBD8
|
[NCBI]
|
0.000928182
|
|
|
gallbladder disease 3
|
[NCBI]
|
0.000928182
|
|
|
systemic lupus erythematosus, susceptibility to, 5
|
[NCBI]
|
0.000928182
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000928182
|
|
|
SLEH1
|
[NCBI]
|
0.000928182
|
|
|
WM2
|
[NCBI]
|
0.000928182
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000928182
|
|
|
DYTCA
|
[NCBI]
|
0.000928182
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000928182
|
|
|
mycobacterium tuberculosis, susceptibility to, 2
|
[NCBI]
|
0.000928182
|
|
|
ETL4
|
[NCBI]
|
0.000928182
|
|
|
EIG4
|
[NCBI]
|
0.000928182
|
|
|
migraine with or without aura, susceptibility to, 8
|
[NCBI]
|
0.000928182
|
|
|
restless legs syndrome, susceptibility to, 5
|
[NCBI]
|
0.000928182
|
|
|
psoriasis susceptibility 7
|
[NCBI]
|
0.000928182
|
|
|
CFEOM3B
|
[NCBI]
|
0.000928182
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000928182
|
|
|
PEE3
|
[NCBI]
|
0.000928182
|
|
|
hypertension, essential, susceptibility to, 6
|
[NCBI]
|
0.000928182
|
|
|
EIG2
|
[NCBI]
|
0.000928182
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000928182
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000928182
|
|
|
malignant hyperthermia, susceptibility to, 6
|
[NCBI]
|
0.000928182
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000928182
|
|
|
atypical mycobacteriosis, familial, x-linked 2
|
[NCBI]
|
0.000928182
|
|
|
gallbladder disease 2
|
[NCBI]
|
0.000928182
|
|
|
major depressive disorder 2
|
[NCBI]
|
0.000928182
|
|
|
hypertension, essential, susceptibility to, 7
|
[NCBI]
|
0.000928182
|
|
|
asthma-related traits, susceptibility to, 4
|
[NCBI]
|
0.000928182
|
|
|
aneurysm, intracranial berry, 4
|
[NCBI]
|
0.000928182
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000928182
|
|
|
hypertension, essential, susceptibility to, 4
|
[NCBI]
|
0.000928182
|
|
|
myopia 11
|
[NCBI]
|
0.000928182
|
|
|
AVSD1
|
[NCBI]
|
0.000928182
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000928182
|
|
|
SPG32
|
[NCBI]
|
0.000928182
|
|
|
azoospermia, nonobstructive
|
[NCBI]
|
0.000928182
|
|
|
hypertension, essential, susceptibility to, 3
|
[NCBI]
|
0.000928182
|
|
|
glioma, familial, 1
|
[NCBI]
|
0.000928182
|
|
|
DFNA43
|
[NCBI]
|
0.000928182
|
|
|
alopecia areata 2
|
[NCBI]
|
0.000928182
|
|
|
leukoencephalopathy with metaphyseal chondrodysplasia
|
[NCBI]
|
0.000928182
|
|
|
prostate cancer, hereditary, 5
|
[NCBI]
|
0.000928182
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000928182
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000928182
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000928182
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.000928182
|
|
|
migraine with aura, susceptibility to, 7
|
[NCBI]
|
0.000928182
|
|
|
hypertension, essential, susceptibility to, 5
|
[NCBI]
|
0.000928182
|
|
|
ATFB5
|
[NCBI]
|
0.000928182
|
|
|
PPR2
|
[NCBI]
|
0.000928182
|
|
|
ETM3
|
[NCBI]
|
0.000928182
|
|
|
OTSC5
|
[NCBI]
|
0.000928182
|
|
|
alzheimer disease 9
|
[NCBI]
|
0.000928182
|
|
|
GOA1
|
[NCBI]
|
0.000928182
|
|
|
schizophrenia 11
|
[NCBI]
|
0.000928182
|
|
|
FEB6
|
[NCBI]
|
0.000928182
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000928182
|
|
|
malignant hyperthermia, susceptibility to, 4
|
[NCBI]
|
0.000928182
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000928182
|
|
|
PSNP3
|
[NCBI]
|
0.000928182
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000928182
|
|
|
prostate cancer, hereditary, 4
|
[NCBI]
|
0.000928182
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.000928182
|
|
|
HDLCQ1
|
[NCBI]
|
0.000928182
|
|
|
DFNB68
|
[NCBI]
|
0.000928182
|
|
|
narcolepsy 3
|
[NCBI]
|
0.000928182
|
|
|
PCOS1
|
[NCBI]
|
0.000922849
|
|
|
NGFB
|
[NCBI]
|
0.000907502
|
|
|
NIDDM
|
[NCBI]
|
0.000895701
|
|
|
PPR
|
[NCBI]
|
0.000877071
|
|
|
NOD2
|
[NCBI]
|
0.000852296
|
|
|
IDDM5
|
[NCBI]
|
0.000847571
|
|
|
VEGF
|
[NCBI]
|
0.000846006
|
|
|
PARK3
|
[NCBI]
|
0.00083377
|
|
|
HPC1
|
[NCBI]
|
0.000802732
|
|
|
AD
|
[NCBI]
|
0.000795792
|
|
|
PCNA
|
[NCBI]
|
0.000773251
|
|
|
FSHMD1A
|
[NCBI]
|
0.000768922
|
|
|
MTR
|
[NCBI]
|
0.000767479
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000759881
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000759881
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000759881
|
|
|
CAPN10
|
[NCBI]
|
0.000742528
|
|
|
TCF7L2
|
[NCBI]
|
0.000732888
|
|
|
AFP
|
[NCBI]
|
0.000732784
|
|
|
BRCA2
|
[NCBI]
|
0.000724394
|
|
|
EIG
|
[NCBI]
|
0.000718153
|
|
|
PWS
|
[NCBI]
|
0.000718133
|
|
|
SCZD9
|
[NCBI]
|
0.000701841
|
|
|
osteoarthritis
|
[NCBI]
|
0.000701652
|
|
|
LRRK2
|
[NCBI]
|
0.000693987
|
|
|
PAND1
|
[NCBI]
|
0.000691634
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000689893
|
|
|
panic disorder 3
|
[NCBI]
|
0.000678115
|
|
|
BMND5
|
[NCBI]
|
0.000678115
|
|
|
NRG1
|
[NCBI]
|
0.00066974
|
|
|
lung cancer 1
|
[NCBI]
|
0.000648272
|
|
|
vestibulopathy, familial
|
[NCBI]
|
0.00062691
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.00062691
|
|
|
ATOD6
|
[NCBI]
|
0.00062691
|
|
|
NIDDM2
|
[NCBI]
|
0.00062691
|
|
|
TLR4
|
[NCBI]
|
0.000622218
|
|
|
GFAP
|
[NCBI]
|
0.000621902
|
|
|
IDDM10
|
[NCBI]
|
0.000605346
|
|
|
EPO
|
[NCBI]
|
0.000597257
|
|
|
AVP
|
[NCBI]
|
0.000587264
|
|
|
ELAC2
|
[NCBI]
|
0.000574862
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000567445
|
|
|
AITD3
|
[NCBI]
|
0.000566023
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000561833
|
|
|
VUR1
|
[NCBI]
|
0.00052717
|
|
|
NIDDM1
|
[NCBI]
|
0.000522757
|
|
|
CDKN2A
|
[NCBI]
|
0.000516832
|
|
|
CDSN
|
[NCBI]
|
0.000512472
|
|
|
EGFR
|
[NCBI]
|
0.000506224
|
|
|
ARMD4
|
[NCBI]
|
0.000505035
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
0.000492169
|
|
|
PD
|
[NCBI]
|
0.000485936
|
|
|
VAMAS1
|
[NCBI]
|
0.000484252
|
|
|
MODY
|
[NCBI]
|
0.000473816
|
|
|
EA3
|
[NCBI]
|
0.000470313
|
|
|
DFNB13
|
[NCBI]
|
0.000470313
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000470313
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000470313
|
|
|
prostate cancer aggressiveness quantitative trait locus on chromosome 19
|
[NCBI]
|
0.000470313
|
|
|
hydrocephalus, autosomal dominant
|
[NCBI]
|
0.000470313
|
|
|
FSHMD1B
|
[NCBI]
|
0.000470313
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000470313
|
|
|
FTSD
|
[NCBI]
|
0.000470313
|
|
|
ATOD5
|
[NCBI]
|
0.000470313
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.000470313
|
|
|
polymicrogyria, unilateral
|
[NCBI]
|
0.000470313
|
|
|
myopia 5
|
[NCBI]
|
0.000470313
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000470313
|
|
|
CRCS1
|
[NCBI]
|
0.000470313
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000470313
|
|
|
MPD3
|
[NCBI]
|
0.000470313
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000470313
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000470313
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000470313
|
|
|
RCM2
|
[NCBI]
|
0.000470313
|
|
|
GLC1I
|
[NCBI]
|
0.000470313
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.000470313
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000470313
|
|
|
DYX8
|
[NCBI]
|
0.000470313
|
|
|
myopia 4
|
[NCBI]
|
0.000470313
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000470313
|
|
|
IBD7
|
[NCBI]
|
0.000470313
|
|
|
AUTS8
|
[NCBI]
|
0.000470313
|
|
|
DYX9
|
[NCBI]
|
0.000470313
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.000470313
|
|
|
PARK6
|
[NCBI]
|
0.000461957
|
|
|
KLK3
|
[NCBI]
|
0.0004618604
|
|
|
obesity
|
[NCBI]
|
0.000459744
|
|
|
RNASEL
|
[NCBI]
|
0.000458861
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000452834
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000449283
|
|
|
DISC1
|
[NCBI]
|
0.00044904
|
|
|
CTLA4
|
[NCBI]
|
0.00044795
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000440604
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.00043914
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
0.000438794
|
|
|
HGF
|
[NCBI]
|
0.000436508
|
|
|
SUMO4
|
[NCBI]
|
0.000429711
|
|
|
CHEK2
|
[NCBI]
|
0.000426689
|
|
|
IL10
|
[NCBI]
|
0.000411223
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000407465
|
|
|
PRODH
|
[NCBI]
|
0.000404067
|
|
|
breast cancer
|
[NCBI]
|
0.000400916
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.000398205
|
|
|
SCA20
|
[NCBI]
|
0.000398205
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000398205
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000398205
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000397829
|
|
|
DTNBP1
|
[NCBI]
|
0.000394911
|
|
|
IDDM12
|
[NCBI]
|
0.000394879
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000394879
|
|
|
CCK
|
[NCBI]
|
0.000392102
|
|
|
APC
|
[NCBI]
|
0.000389759
|
|
|
AUTS10
|
[NCBI]
|
0.00038536
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.000374048
|
|
|
MAOA
|
[NCBI]
|
0.000373898
|
|
|
loc387715 gene
|
[NCBI]
|
0.000371133
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
0.000369115
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000365855
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
0.000363169
|
|
|
ACE
|
[NCBI]
|
0.000361645
|
|
|
alcohol dependence
|
[NCBI]
|
0.000361405
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000361238
|
|
|
FH
|
[NCBI]
|
0.000360792
|
|
|
MTHFR
|
[NCBI]
|
0.000350889
|
|
|
graves disease
|
[NCBI]
|
0.000350391
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
0.000345184
|
|
|
CMM2
|
[NCBI]
|
0.000344797
|
|
|
SOD2
|
[NCBI]
|
0.000341233
|
|
|
PON1
|
[NCBI]
|
0.000339571
|
|
|
MG
|
[NCBI]
|
0.000326569
|
|
|
ACHE
|
[NCBI]
|
0.000323651
|
|
|
hypertension, essential
|
[NCBI]
|
0.000323344
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
0.000322424
|
|
|
FTLDU
|
[NCBI]
|
0.000321104
|
|
|
IGAD1
|
[NCBI]
|
0.000320331
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000315045
|
|
|
ARMD7
|
[NCBI]
|
0.000314929
|
|
|
CCHCR1
|
[NCBI]
|
0.000313447
|
|
|
SLC22A4
|
[NCBI]
|
0.000313447
|
|
|
hip dysplasia, beukes type
|
[NCBI]
|
0.000313252
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000313252
|
|
|
EJM2
|
[NCBI]
|
0.000313252
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000313252
|
|
|
CSE
|
[NCBI]
|
0.000313252
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000313252
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000313252
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000313252
|
|
|
IDDM11
|
[NCBI]
|
0.000313252
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
0.000313252
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000313252
|
|
|
PTPN22
|
[NCBI]
|
0.000310896
|
|
|
PALB2
|
[NCBI]
|
0.000306915
|
|
|
acne inversa, familial
|
[NCBI]
|
0.0003038799
|
|
|
AS
|
[NCBI]
|
0.000302542
|
|
|
SCZD4
|
[NCBI]
|
0.000302263
|
|
|
MSR1
|
[NCBI]
|
0.000292877
|
|
|
stroke, ischemic
|
[NCBI]
|
0.000292139
|
|
|
HLA-DRB1
|
[NCBI]
|
0.000291933
|
|
|
FMF
|
[NCBI]
|
0.000290944
|
|
|
MDD
|
[NCBI]
|
0.000290923864
|
|
|
RP
|
[NCBI]
|
0.000288589
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
0.000288522
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
0.000288522
|
|
|
SLEB1
|
[NCBI]
|
0.000288522
|
|
|
PDCD1
|
[NCBI]
|
0.000285557
|
|
|
RET
|
[NCBI]
|
0.000284117
|
|
|
AIS1
|
[NCBI]
|
0.000282956
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
0.000282956
|
|
|
SCZD10
|
[NCBI]
|
0.0002789575
|
|
|
SPDA1
|
[NCBI]
|
0.0002706
|
|
|
MLH1
|
[NCBI]
|
0.000270419
|
|
|
GHDD
|
[NCBI]
|
0.000269987
|
|
|
PFHB2
|
[NCBI]
|
0.000269987
|
|
|
SPS
|
[NCBI]
|
0.000266794
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
0.000263397
|
|
|
PN
|
[NCBI]
|
0.000263397
|
|
|
MICA
|
[NCBI]
|
0.000258551
|
|
|
DYX2
|
[NCBI]
|
0.000253175
|
|
|
BTBD9
|
[NCBI]
|
0.000245524
|
|
|
IBD10
|
[NCBI]
|
0.000242101
|
|
|
VUR2
|
[NCBI]
|
0.000242101
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
0.000242101
|
|
|
fanconi anemia, complementation group n
|
[NCBI]
|
0.000242101
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
0.000242101
|
|
|
LFS2
|
[NCBI]
|
0.000242101
|
|
|
IL23R
|
[NCBI]
|
0.0002410643
|
|
|
PDB
|
[NCBI]
|
0.000237797
|
|
|
HSCR1
|
[NCBI]
|
0.000230462
|
|
|
lynch syndrome i
|
[NCBI]
|
0.000229991
|
|
|
NAT1
|
[NCBI]
|
0.0002271471
|
|
|
ETL2
|
[NCBI]
|
0.000225269
|
|
|
F3
|
[NCBI]
|
0.0002241165
|
|
|
PRNP
|
[NCBI]
|
0.000223095
|
|
|
MSH2
|
[NCBI]
|
0.0002203123
|
|
|
DYT6
|
[NCBI]
|
0.000220132
|
|
|
DYX3
|
[NCBI]
|
0.000220132
|
|
|
MYP3
|
[NCBI]
|
0.000220132
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000220132
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.000220132
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000220132
|
|
|
DYX5
|
[NCBI]
|
0.000220132
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000220132
|
|
|
PARK11
|
[NCBI]
|
0.000220132
|
|
|
ARVD5
|
[NCBI]
|
0.000220132
|
|
|
ARVD3
|
[NCBI]
|
0.000220132
|
|
|
speech-sound disorder
|
[NCBI]
|
0.000220132
|
|
|
MYP1
|
[NCBI]
|
0.000220132
|
|
|
BRCA3
|
[NCBI]
|
0.000220132
|
|
|
PJS
|
[NCBI]
|
0.0002192189
|
|
|
SPG15
|
[NCBI]
|
0.0002189269
|
|
|
ENPP1
|
[NCBI]
|
0.000218701
|
|
|
PARK8
|
[NCBI]
|
0.000217415
|
|
|
FTO
|
[NCBI]
|
0.0002173576
|
|
|
SMEI
|
[NCBI]
|
0.000216033
|
|
|
MAPT
|
[NCBI]
|
0.0002133014
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.0002128867
|
|
|
RYR1
|
[NCBI]
|
0.0002103276
|
|
|
NPPA
|
[NCBI]
|
0.0002070075
|
|
|
CDKAL1
|
[NCBI]
|
0.0002061138
|
|
|
kawasaki disease
|
[NCBI]
|
0.000205738
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
0.0002046401
|
|
|
GIST
|
[NCBI]
|
0.0002045156
|
|
|
NCSTN
|
[NCBI]
|
0.0002019425
|
|
|
SFTPA1
|
[NCBI]
|
0.0002016078
|
|
|
INS
|
[NCBI]
|
0.0001994348
|
|
|
g72 gene
|
[NCBI]
|
0.0001983693
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
0.000197961
|
|
|
DHFR
|
[NCBI]
|
0.0001947636
|
|
|
MC1R
|
[NCBI]
|
0.0001939567
|
|
|
HLA-C
|
[NCBI]
|
0.0001930158
|
|
|
SLC30A8
|
[NCBI]
|
0.0001927416
|
|
|
IGF2BP2
|
[NCBI]
|
0.0001927416
|
|
|
PSNP2
|
[NCBI]
|
0.0001905674
|
|
|
EA4
|
[NCBI]
|
0.0001905674
|
|
|
MCDU
|
[NCBI]
|
0.0001905674
|
|
|
prosopagnosia, hereditary
|
[NCBI]
|
0.0001905674
|
|
|
CHDM
|
[NCBI]
|
0.0001905674
|
|
|
aHUS
|
[NCBI]
|
0.0001902614
|
|
|
BMND3
|
[NCBI]
|
0.0001899745
|
|
|
RNASE3
|
[NCBI]
|
0.0001887418
|
|
|
PSEN1
|
[NCBI]
|
0.0001879977
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.0001869486
|
|
|
LMNA
|
[NCBI]
|
0.000186888
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
0.0001868436
|
|
|
GCLM
|
[NCBI]
|
0.0001845814
|
|
|
CDH1
|
[NCBI]
|
0.0001824973
|
|
|
ALS1
|
[NCBI]
|
0.0001821478
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.0001811373
|
|
|
ARMD1
|
[NCBI]
|
0.0001809567
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.0001808521
|
|
|
PHOX2B
|
[NCBI]
|
0.0001804715
|
|
|
HLA-DPB1
|
[NCBI]
|
0.0001799056
|
|
|
HCRTR2
|
[NCBI]
|
0.0001796468
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
0.0001779155
|
|
|
IDD
|
[NCBI]
|
0.0001779155
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
0.0001777571
|
|
|
SCZD8
|
[NCBI]
|
0.0001770715
|
|
|
DRD2
|
[NCBI]
|
0.0001763416
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
0.0001763273
|
|
|
SLE
|
[NCBI]
|
0.00017555967
|
|
|
IFNGR1
|
[NCBI]
|
0.000175549
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
0.0001742041
|
|
|
CELIAC3
|
[NCBI]
|
0.0001742041
|
|
|
ATOD4
|
[NCBI]
|
0.0001742041
|
|
|
PEE4
|
[NCBI]
|
0.0001742041
|
|
|
ARMD10
|
[NCBI]
|
0.0001742041
|
|
|
ADCAD1
|
[NCBI]
|
0.0001742041
|
|
|
SLEB2
|
[NCBI]
|
0.0001742041
|
|
|
FLG
|
[NCBI]
|
0.0001729363
|
|
|
TPH2
|
[NCBI]
|
0.0001719901
|
|
|
PLEKHA1
|
[NCBI]
|
0.0001708454
|
|
|
DYX1C1
|
[NCBI]
|
0.0001706061
|
|
|
TLR5
|
[NCBI]
|
0.000170419
|
|
|
ALOX5AP
|
[NCBI]
|
0.0001695707
|
|
|
DRD4
|
[NCBI]
|
0.0001694803
|
|
|
PPPP
|
[NCBI]
|
0.0001690719
|
|
|
ARVD4
|
[NCBI]
|
0.0001690719
|
|
|
CCR5
|
[NCBI]
|
0.0001681078
|
|
|
ARVD1
|
[NCBI]
|
0.000167465
|
|
|
EKD1
|
[NCBI]
|
0.0001674517
|
|
|
HLA-DQB1
|
[NCBI]
|
0.0001672758
|
|
|
NPY
|
[NCBI]
|
0.0001654485
|
|
|
ADA
|
[NCBI]
|
0.0001646453
|
|
|
ZDHHC8
|
[NCBI]
|
0.0001642989
|
|
|
ATG16L1
|
[NCBI]
|
0.0001642989
|
|
|
ALD
|
[NCBI]
|
0.0001625685
|
|
|
GRN
|
[NCBI]
|
0.0001618578
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
0.0001607327
|
|
|
temporal arteritis
|
[NCBI]
|
0.0001599034
|
|
|
CLEC16A
|
[NCBI]
|
0.0001596674
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
0.0001596674
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
0.0001577094
|
|
|
SCA27
|
[NCBI]
|
0.0001577094
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000157384
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000157384
|
|
|
ETM2
|
[NCBI]
|
0.000157384
|
|
|
AD14
|
[NCBI]
|
0.000157384
|
|
|
WT3
|
[NCBI]
|
0.000157384
|
|
|
AD13
|
[NCBI]
|
0.000157384
|
|
|
SCZD2
|
[NCBI]
|
0.0001572036
|
|
|
CAT
|
[NCBI]
|
0.0001566742
|
|
|
INSIG2
|
[NCBI]
|
0.0001565146
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.0001529087
|
|
|
MHS1
|
[NCBI]
|
0.0001517135
|
|
|
FABP2
|
[NCBI]
|
0.0001516381
|
|
|
MUTYH
|
[NCBI]
|
0.0001490241
|
|
|
PGL4
|
[NCBI]
|
0.0001489066
|
|
|
holoprosencephaly
|
[NCBI]
|
0.0001474689
|
|
|
IRF6
|
[NCBI]
|
0.0001474396
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.0001459516
|
|
|
MYP2
|
[NCBI]
|
0.0001459516
|
|
|
HTRA1
|
[NCBI]
|
0.0001458527
|
|
|
DFSP
|
[NCBI]
|
0.0001451807
|
|
|
PARK2
|
[NCBI]
|
0.0001449327
|
|
|
HHEX
|
[NCBI]
|
0.0001445086
|
|
|
CELIAC4
|
[NCBI]
|
0.000144238
|
|
|
PDE4D
|
[NCBI]
|
0.0001425079
|
|
|
g30 gene
|
[NCBI]
|
0.0001421954
|
|
|
KCNJ11
|
[NCBI]
|
0.0001420159
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
0.0001405357
|
|
|
MJD
|
[NCBI]
|
0.0001401742
|
|
|
MSH6
|
[NCBI]
|
0.0001398249
|
|
|
HEPOD
|
[NCBI]
|
0.0001395371
|
|
|
SLC2A10
|
[NCBI]
|
0.0001375639
|
|
|
DLG5
|
[NCBI]
|
0.0001375639
|
|
|
SLC19A1
|
[NCBI]
|
0.0001374314
|
|
|
testicular tumors
|
[NCBI]
|
0.0001364107
|
|
|
ATM
|
[NCBI]
|
0.0001357905
|
|
|
HNPCC2
|
[NCBI]
|
0.0001356849
|
|
|
pancreatic carcinoma
|
[NCBI]
|
0.0001353621
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
0.0001351529
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
0.0001351529
|
|
|
GSTM1
|
[NCBI]
|
0.0001348839
|
|
|
HCFP1
|
[NCBI]
|
0.0001340199
|
|
|
CHAT
|
[NCBI]
|
0.0001327676
|
|
|
gastric cancer
|
[NCBI]
|
0.0001318371
|
|
|
TS
|
[NCBI]
|
0.0001314355
|
|
|
ADAM33
|
[NCBI]
|
0.0001313607
|
|
|
PCD
|
[NCBI]
|
0.0001305333
|
|
|
SLC6A4
|
[NCBI]
|
0.0001305295
|
|
|
CMT4A
|
[NCBI]
|
0.0001304194
|
|
|
ELN
|
[NCBI]
|
0.0001298162
|
|
|
TLR2
|
[NCBI]
|
0.0001296742
|
|
|
DGS
|
[NCBI]
|
0.0001292113
|
|
|
MFN2
|
[NCBI]
|
0.0001290458
|
|
|
IL4R
|
[NCBI]
|
0.0001284598
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
0.0001283121
|
|
|
GSTT1
|
[NCBI]
|
0.0001263294
|
|
|
EDC
|
[NCBI]
|
0.0001258468
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.0001257131
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
0.000124079
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
0.000124079
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
0.000124079
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
0.000124079
|
|
|
SP110
|
[NCBI]
|
0.0001231232
|
|
|
ZFAT1
|
[NCBI]
|
0.0001227535
|
|
|
FCGR3B
|
[NCBI]
|
0.0001227535
|
|
|
ZC3H12D
|
[NCBI]
|
0.0001227535
|
|
|
SLC12A8
|
[NCBI]
|
0.0001227535
|
|
|
BOS1
|
[NCBI]
|
0.0001219846
|
|
|
TH
|
[NCBI]
|
0.0001216528
|
|
|
VCP
|
[NCBI]
|
0.0001215693
|
|
|
CHS
|
[NCBI]
|
0.0001213139
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.0001211192
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
0.0001210441
|
|
|
craniosynostosis with ocular abnormalities and hallucal defects
|
[NCBI]
|
0.0001210441
|
|
|
AMCBX1
|
[NCBI]
|
0.0001210441
|
|
|
ADCAD2
|
[NCBI]
|
0.0001210441
|
|
|
oligodontia-colorectal cancer syndrome
|
[NCBI]
|
0.0001210441
|
|
|
polysubstance abuse, susceptibility to
|
[NCBI]
|
0.0001210441
|
|
|
HYT8
|
[NCBI]
|
0.0001210441
|
|
|
NEM7
|
[NCBI]
|
0.0001210441
|
|
|
primordial germ cell tumor susceptibility locus 1
|
[NCBI]
|
0.0001210441
|
|
|
folate level in erythrocytes
|
[NCBI]
|
0.0001210441
|
|
|
FSGS3
|
[NCBI]
|
0.0001210441
|
|
|
legionnaire disease, susceptibility to
|
[NCBI]
|
0.0001210441
|
|
|
AGS5
|
[NCBI]
|
0.0001210441
|
|
|
tinea imbricata, susceptibility to
|
[NCBI]
|
0.0001210441
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
0.0001210441
|
|
|
gallbladder disease 4
|
[NCBI]
|
0.0001210441
|
|
|
IL1A
|
[NCBI]
|
0.0001206987
|
|
|
GPR154
|
[NCBI]
|
0.0001201675
|
|
|
nevi flammei, familial multiple
|
[NCBI]
|
0.0001197253
|
|
|
CLN4B
|
[NCBI]
|
0.0001197253
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.0001197253
|
|
|
ADH2
|
[NCBI]
|
0.0001192179
|
|
|
MBP
|
[NCBI]
|
0.0001185587
|
|
|
SRD5A2
|
[NCBI]
|
0.0001180066
|
|
|
FRZB
|
[NCBI]
|
0.0001176642
|
|
|
HNMT
|
[NCBI]
|
0.0001173645
|
|
|
JAE
|
[NCBI]
|
0.0001172382
|
|
|
sarcoidosis
|
[NCBI]
|
0.0001167191
|
|
|
CCL11
|
[NCBI]
|
0.0001154947
|
|
|
PINK1
|
[NCBI]
|
0.0001150784
|
|
|
SQSTM1
|
[NCBI]
|
0.0001148388
|
|
|
HLA-B
|
[NCBI]
|
0.0001146146
|
|
|
FRAP1
|
[NCBI]
|
0.0001136393
|
|
|
ALDH2
|
[NCBI]
|
0.0001132044
|
|
|
IOSCA
|
[NCBI]
|
0.0001125244
|
|
|
GBY
|
[NCBI]
|
0.0001125244
|
|
|
PGL2
|
[NCBI]
|
0.0001125244
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.0001124293
|
|
|
SFTPB
|
[NCBI]
|
0.0001123635
|
|
|
PDYN
|
[NCBI]
|
0.0001117977
|
|
|
JME
|
[NCBI]
|
0.0001107403
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
0.0001101303
|
|
|
UL
|
[NCBI]
|
0.000108938
|
|
|
SHEP1
|
[NCBI]
|
0.0001086048
|
|
|
lung cancer
|
[NCBI]
|
0.0001085857
|
|
|
TNFRSF11B
|
[NCBI]
|
0.0001082339
|
|
|
ADHD
|
[NCBI]
|
0.0001080859
|
|
|
GAPDH
|
[NCBI]
|
0.0001077352
|
|
|
ADAR
|
[NCBI]
|
0.0001076377
|
|
|
TG
|
[NCBI]
|
0.0001073897
|
|
|
KCNJ2
|
[NCBI]
|
0.0001067441
|
|
|
CYP46A1
|
[NCBI]
|
0.000106441
|
|
|
ANGPTL2
|
[NCBI]
|
0.000106441
|
|
|
CFHR3
|
[NCBI]
|
0.000106441
|
|
|
RUNX1
|
[NCBI]
|
0.0001058886
|
|
|
IL12B
|
[NCBI]
|
0.0001058608
|
|
|
TFPI
|
[NCBI]
|
0.0001050555
|
|
|
CRH
|
[NCBI]
|
0.0001049806
|
|
|
PTHLH
|
[NCBI]
|
0.0001045424
|
|
|
TNFRSF1B
|
[NCBI]
|
0.0001039832
|
|
|
complement factor h deficiency
|
[NCBI]
|
0.0001039202
|
|
|
factor v deficiency
|
[NCBI]
|
0.0001032272
|
|
|
PTPN2
|
[NCBI]
|
0.0001030075
|
|
|
GANC
|
[NCBI]
|
0.0001030075
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.0001023602
|
|
|
CST3
|
[NCBI]
|
0.000100497
|
|
|
PLUNC
|
[NCBI]
|
0.0001003976
|
|
|
SH2B3
|
[NCBI]
|
0.0001003976
|
|
|
IMPA2
|
[NCBI]
|
0.0001003976
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
0.0001001553
|
|
|
ICAM1
|
[NCBI]
|
9.96869e-05
|
|
|
angioma, tufted
|
[NCBI]
|
9.90908e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
9.90908e-05
|
|
|
hyperlipoproteinemia, type v
|
[NCBI]
|
9.90908e-05
|
|
|
ME2
|
[NCBI]
|
9.88137e-05
|
|
|
TGFB3
|
[NCBI]
|
9.83169e-05
|
|
|
PNKD1
|
[NCBI]
|
9.82161e-05
|
|
|
IFNG
|
[NCBI]
|
9.7641e-05
|
|
|
FA
|
[NCBI]
|
9.75625e-05
|
|
|
endometrial cancer
|
[NCBI]
|
9.68859e-05
|
|
|
CASP8
|
[NCBI]
|
9.66511e-05
|
|
|
CBLB
|
[NCBI]
|
9.65372e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
9.63612e-05
|
|
|
AUTS4
|
[NCBI]
|
9.56494e-05
|
|
|
CFHR1
|
[NCBI]
|
9.50301e-05
|
|
|
BOR2
|
[NCBI]
|
9.40665e-05
|
|
|
EVER2
|
[NCBI]
|
9.27584e-05
|
|
|
G6PD
|
[NCBI]
|
9.25673e-05
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
9.2367e-05
|
|
|
MTRNR1
|
[NCBI]
|
9.22629e-05
|
|
|
MVA
|
[NCBI]
|
9.19131e-05
|
|
|
SMAX1
|
[NCBI]
|
9.06453e-05
|
|
|
MVP
|
[NCBI]
|
8.95701e-05
|
|
|
HBB
|
[NCBI]
|
8.87329e-05
|
|
|
FTD
|
[NCBI]
|
8.82632e-05
|
|
|
SCN5A
|
[NCBI]
|
8.7542e-05
|
|
|
PARK7
|
[NCBI]
|
8.69364e-05
|
|
|
IBMPFD
|
[NCBI]
|
8.69364e-05
|
|
|
CMT4B1
|
[NCBI]
|
8.69364e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
8.69364e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
8.69364e-05
|
|
|
AR
|
[NCBI]
|
8.68668e-05
|
|
|
TSD
|
[NCBI]
|
8.67391e-05
|
|
|
FHM2
|
[NCBI]
|
8.65903e-05
|
|
|
MEF2A
|
[NCBI]
|
8.59265e-05
|
|
|
BRIP1
|
[NCBI]
|
8.58817e-05
|
|
|
OPTN
|
[NCBI]
|
8.54441e-05
|
|
|
OCD1
|
[NCBI]
|
8.49412e-05
|
|
|
NRCLP1
|
[NCBI]
|
8.48552e-05
|
|
|
SCA6
|
[NCBI]
|
8.47237e-05
|
|
|
TREX1
|
[NCBI]
|
8.43391e-05
|
|
|
PLXNA2
|
[NCBI]
|
8.42817e-05
|
|
|
SLAMF6
|
[NCBI]
|
8.42817e-05
|
|
|
AACT
|
[NCBI]
|
8.39366e-05
|
|
|
NOS2A
|
[NCBI]
|
8.37067e-05
|
|
|
PPARG
|
[NCBI]
|
8.33208e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
8.31849e-05
|
|
|
PARK4
|
[NCBI]
|
8.31002e-05
|
|
|
NQO1
|
[NCBI]
|
8.29344e-05
|
|
|
FPLD2
|
[NCBI]
|
8.28342e-05
|
|
|
CDKN2B
|
[NCBI]
|
8.27897e-05
|
|
|
SNCA
|
[NCBI]
|
8.26294e-05
|
|
|
herpes simplex encephalitis, unc93b-deficient
|
[NCBI]
|
8.25624e-05
|
|
|
FCHL
|
[NCBI]
|
8.24515e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
8.23498e-05
|
|
|
GBS
|
[NCBI]
|
8.2304e-05
|
|
|
PMD
|
[NCBI]
|
8.21477e-05
|
|
|
PSEN2
|
[NCBI]
|
8.18764e-05
|
|
|
GABRA4
|
[NCBI]
|
8.16718e-05
|
|
|
IGF2
|
[NCBI]
|
8.15838e-05
|
|
|
HNF1B
|
[NCBI]
|
8.12773e-05
|
|
|
IL1B
|
[NCBI]
|
8.09635e-05
|
|
|
FLCN
|
[NCBI]
|
8.00385e-05
|
|
|
GARS
|
[NCBI]
|
7.98424e-05
|
|
|
aplasia cutis congenita with epibulbar dermoids
|
[NCBI]
|
7.98177e-05
|
|
|
MAOB
|
[NCBI]
|
7.96082e-05
|
|
|
OFC1
|
[NCBI]
|
7.94996e-05
|
|
|
ECA1
|
[NCBI]
|
7.94862e-05
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
7.94862e-05
|
|
|
inclusion body myositis
|
[NCBI]
|
7.94862e-05
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
7.94862e-05
|
|
|
HMN1
|
[NCBI]
|
7.94862e-05
|
|
|
MNG1
|
[NCBI]
|
7.94862e-05
|
|
|
KSS
|
[NCBI]
|
7.94403e-05
|
|
|
EVER1
|
[NCBI]
|
7.93922e-05
|
|
|
CMT4B2
|
[NCBI]
|
7.85136e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.84043e-05
|
|
|
ENG
|
[NCBI]
|
7.79434e-05
|
|
|
TAS2R16
|
[NCBI]
|
7.78114e-05
|
|
|
GABRD
|
[NCBI]
|
7.78114e-05
|
|
|
BRAF
|
[NCBI]
|
7.7418e-05
|
|
|
STK11
|
[NCBI]
|
7.71814e-05
|
|
|
SMN2
|
[NCBI]
|
7.71814e-05
|
|
|
POLG
|
[NCBI]
|
7.68167e-05
|
|
|
IL2
|
[NCBI]
|
7.66817e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
7.66483e-05
|
|
|
PARP1
|
[NCBI]
|
7.64117e-05
|
|
|
STAT6
|
[NCBI]
|
7.64117e-05
|
|
|
RAPSN
|
[NCBI]
|
7.6262e-05
|
|
|
SHEP2
|
[NCBI]
|
7.60495e-05
|
|
|
DCDC2
|
[NCBI]
|
7.59587e-05
|
|
|
SMARCB1
|
[NCBI]
|
7.58028e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
7.53333e-05
|
|
|
HFE3
|
[NCBI]
|
7.51963e-05
|
|
|
EXO1
|
[NCBI]
|
7.49876e-05
|
|
|
PXE
|
[NCBI]
|
7.49627e-05
|
|
|
DRD3
|
[NCBI]
|
7.48086e-05
|
|
|
HLA-G
|
[NCBI]
|
7.48086e-05
|
|
|
ATXN8OS
|
[NCBI]
|
7.40721e-05
|
|
|
BTNL2
|
[NCBI]
|
7.33488e-05
|
|
|
ANKK1
|
[NCBI]
|
7.33488e-05
|
|
|
MIF
|
[NCBI]
|
7.24829e-05
|
|
|
CNTF
|
[NCBI]
|
7.24547e-05
|
|
|
ARMD9
|
[NCBI]
|
7.21132e-05
|
|
|
metaphyseal dysplasia without hypotrichosis
|
[NCBI]
|
7.21132e-05
|
|
|
periodontitis, chronic
|
[NCBI]
|
7.21132e-05
|
|
|
SHEP9
|
[NCBI]
|
7.21132e-05
|
|
|
MEN4
|
[NCBI]
|
7.21132e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
7.21132e-05
|
|
|
brain small vessel disease with hemorrhage
|
[NCBI]
|
7.21132e-05
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
7.21132e-05
|
|
|
acne, adult
|
[NCBI]
|
7.21132e-05
|
|
|
IPD1
|
[NCBI]
|
7.21132e-05
|
|
|
capillary malformation-arteriovenous malformation
|
[NCBI]
|
7.21132e-05
|
|
|
SCA16
|
[NCBI]
|
7.21132e-05
|
|
|
beta-hydroxyisobutyryl coa deacylase, deficiency of
|
[NCBI]
|
7.21132e-05
|
|
|
MRX45
|
[NCBI]
|
7.21132e-05
|
|
|
orofacial cleft 6
|
[NCBI]
|
7.21132e-05
|
|
|
bor-duane hydrocephalus contiguous gene syndrome
|
[NCBI]
|
7.21132e-05
|
|
|
HMN7B
|
[NCBI]
|
7.21132e-05
|
|
|
HGPS
|
[NCBI]
|
7.20966e-05
|
|
|
POMC
|
[NCBI]
|
7.20236e-05
|
|
|
CMT4D
|
[NCBI]
|
7.12508e-05
|
|
|
CMT4C
|
[NCBI]
|
7.12508e-05
|
|
|
XRCC3
|
[NCBI]
|
7.1246e-05
|
|
|
TLR10
|
[NCBI]
|
7.1246e-05
|
|
|
PALLD
|
[NCBI]
|
7.1246e-05
|
|
|
SMA3
|
[NCBI]
|
7.11508e-05
|
|
|
apc gene
|
[NCBI]
|
7.11256e-05
|
|
|
CMH
|
[NCBI]
|
7.1029e-05
|
|
|
DBH
|
[NCBI]
|
7.09564e-05
|
|
|
SMN1
|
[NCBI]
|
7.08692e-05
|
|
|
TNFSF6
|
[NCBI]
|
7.03081e-05
|
|
|
PHB
|
[NCBI]
|
6.97683e-05
|
|
|
IL8
|
[NCBI]
|
6.96707e-05
|
|
|
EDN1
|
[NCBI]
|
6.96402e-05
|
|
|
UCHL1
|
[NCBI]
|
6.90476e-05
|
|
|
HP
|
[NCBI]
|
6.88168e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
6.86315e-05
|
|
|
twinning, monozygotic
|
[NCBI]
|
6.83065e-05
|
|
|
CMAH
|
[NCBI]
|
6.83065e-05
|
|
|
MLH3
|
[NCBI]
|
6.77157e-05
|
|
|
NEB
|
[NCBI]
|
6.72946e-05
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
6.71111e-05
|
|
|
BDNF
|
[NCBI]
|
6.702838e-05
|
|
|
C5
|
[NCBI]
|
6.68042e-05
|
|
|
IP
|
[NCBI]
|
6.67363e-05
|
|
|
osteoporosis
|
[NCBI]
|
6.65324e-05
|
|
|
HMOX1
|
[NCBI]
|
6.59014e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
6.5761e-05
|
|
|
KCNQ1OT1
|
[NCBI]
|
6.57167e-05
|
|
|
MAFD2
|
[NCBI]
|
6.56717e-05
|
|
|
EPHX1
|
[NCBI]
|
6.51325e-05
|
|
|
MYD88
|
[NCBI]
|
6.4925e-05
|
|
|
CMT2A2
|
[NCBI]
|
6.48999e-05
|
|
|
LFS1
|
[NCBI]
|
6.44774e-05
|
|
|
CTSD
|
[NCBI]
|
6.42483e-05
|
|
|
urinary tract infections, recurrent, susceptibility to
|
[NCBI]
|
6.41504e-05
|
|
|
myopathy, spheroid body
|
[NCBI]
|
6.41504e-05
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
6.41504e-05
|
|
|
geographic tongue and fissured tongue
|
[NCBI]
|
6.41504e-05
|
|
|
gambling, pathologic
|
[NCBI]
|
6.41504e-05
|
|
|
IRGM
|
[NCBI]
|
6.38553e-05
|
|
|
NR4A2
|
[NCBI]
|
6.38523e-05
|
|
|
PARK1
|
[NCBI]
|
6.34521e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
6.34521e-05
|
|
|
ETM1
|
[NCBI]
|
6.33726e-05
|
|
|
IGER
|
[NCBI]
|
6.27611e-05
|
|
|
ABSD
|
[NCBI]
|
6.24265e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
6.24265e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
6.24265e-05
|
|
|
behcet syndrome
|
[NCBI]
|
6.23924e-05
|
|
|
FGF14
|
[NCBI]
|
6.23482e-05
|
|
|
SEMA5A
|
[NCBI]
|
6.23482e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
6.2023e-05
|
|
|
IL4
|
[NCBI]
|
6.17837e-05
|
|
|
OPRM1
|
[NCBI]
|
6.1661e-05
|
|
|
kyphomelic dysplasia
|
[NCBI]
|
6.15305e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.14943e-05
|
|
|
SELP
|
[NCBI]
|
6.1439e-05
|
|
|
RNPEPL1
|
[NCBI]
|
6.13747e-05
|
|
|
NDNL2
|
[NCBI]
|
6.13747e-05
|
|
|
SLC9A9
|
[NCBI]
|
6.13747e-05
|
|
|
emsy gene
|
[NCBI]
|
6.13747e-05
|
|
|
flj10986
|
[NCBI]
|
6.13747e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
6.13747e-05
|
|
|
SPG25
|
[NCBI]
|
6.13747e-05
|
|
|
RNF167
|
[NCBI]
|
6.13747e-05
|
|
|
narcolepsy candidate region gene 1a
|
[NCBI]
|
6.13747e-05
|
|
|
SLC26A11
|
[NCBI]
|
6.13747e-05
|
|
|
MYO3B
|
[NCBI]
|
6.13747e-05
|
|
|
HSPA12B
|
[NCBI]
|
6.13747e-05
|
|
|
DIRC2
|
[NCBI]
|
6.13747e-05
|
|
|
g8 protein
|
[NCBI]
|
6.13747e-05
|
|
|
C10ORF6
|
[NCBI]
|
6.13747e-05
|
|
|
cancer/testis antigen km-hn-1
|
[NCBI]
|
6.13747e-05
|
|
|
hsc20, e. coli, homolog of
|
[NCBI]
|
6.13747e-05
|
|
|
SCNM1
|
[NCBI]
|
6.13747e-05
|
|
|
DCUN1D1
|
[NCBI]
|
6.13747e-05
|
|
|
RASAL2
|
[NCBI]
|
6.13747e-05
|
|
|
MIAT
|
[NCBI]
|
6.13747e-05
|
|
|
ORMDL3
|
[NCBI]
|
6.13747e-05
|
|
|
PPH1
|
[NCBI]
|
6.11571e-05
|
|
|
EPHX2
|
[NCBI]
|
6.10315e-05
|
|
|
HAVCR1
|
[NCBI]
|
6.10315e-05
|
|
|
MBD4
|
[NCBI]
|
6.10315e-05
|
|
|
SCZD1
|
[NCBI]
|
6.08664e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
6.04391e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
6.04391e-05
|
|
|
ATS
|
[NCBI]
|
6.00107e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
5.9873e-05
|
|
|
CYLD1
|
[NCBI]
|
5.98645e-05
|
|
|
COL9A3
|
[NCBI]
|
5.95983e-05
|
|
|
GBD1
|
[NCBI]
|
5.94828e-05
|
|
|
focal epithelial hyperplasia, oral
|
[NCBI]
|
5.91614e-05
|
|
|
hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
|
[NCBI]
|
5.91614e-05
|
|
|
SHBG
|
[NCBI]
|
5.89404e-05
|
|
|
PRDX1
|
[NCBI]
|
5.80912e-05
|
|
|
FGF20
|
[NCBI]
|
5.80912e-05
|
|
|
OLIG2
|
[NCBI]
|
5.78717e-05
|
|
|
MMP3
|
[NCBI]
|
5.78479e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
5.78284e-05
|
|
|
MYOC
|
[NCBI]
|
5.77072e-05
|
|
|
FRDA
|
[NCBI]
|
5.76875e-05
|
|
|
PTGS2
|
[NCBI]
|
5.75124e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
5.72431e-05
|
|
|
AIP
|
[NCBI]
|
5.67745e-05
|
|
|
ERBB3
|
[NCBI]
|
5.67745e-05
|
|
|
APOA5
|
[NCBI]
|
5.67745e-05
|
|
|
ASPN
|
[NCBI]
|
5.67745e-05
|
|
|
lipase deficiency, combined
|
[NCBI]
|
5.64151e-05
|
|
|
FGF7
|
[NCBI]
|
5.63476e-05
|
|
|
IL1RN
|
[NCBI]
|
5.62031e-05
|
|
|
SEPN1
|
[NCBI]
|
5.61885e-05
|
|
|
GIP
|
[NCBI]
|
5.59386e-05
|
|
|
CDKN1B
|
[NCBI]
|
5.55277e-05
|
|
|
TTID
|
[NCBI]
|
5.5113e-05
|
|
|
CYP3A4
|
[NCBI]
|
5.5011e-05
|
|
|
medulloblastoma
|
[NCBI]
|
5.48947e-05
|
|
|
DA2B
|
[NCBI]
|
5.48947e-05
|
|
|
CYP1A2
|
[NCBI]
|
5.4808e-05
|
|
|
IRF2
|
[NCBI]
|
5.46814e-05
|
|
|
COL9A2
|
[NCBI]
|
5.46814e-05
|
|
|
SCGB3A2
|
[NCBI]
|
5.46814e-05
|
|
|
GSTP1
|
[NCBI]
|
5.46338e-05
|
|
|
MCPH6
|
[NCBI]
|
5.44637e-05
|
|
|
MRT3
|
[NCBI]
|
5.44637e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
5.44637e-05
|
|
|
PPROM
|
[NCBI]
|
5.44637e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
5.44637e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
5.44637e-05
|
|
|
FEB8
|
[NCBI]
|
5.44637e-05
|
|
|
ACFD
|
[NCBI]
|
5.44637e-05
|
|
|
EDMD3
|
[NCBI]
|
5.44637e-05
|
|
|
FEB3
|
[NCBI]
|
5.44637e-05
|
|
|
aminoacylase 1 deficiency
|
[NCBI]
|
5.44637e-05
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
5.44637e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
5.44637e-05
|
|
|
basal cell carcinoma, multiple
|
[NCBI]
|
5.44637e-05
|
|
|
BOS3
|
[NCBI]
|
5.44637e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
5.42574e-05
|
|
|
RELN
|
[NCBI]
|
5.42355e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
5.40394e-05
|
|
|
krabbe disease
|
[NCBI]
|
5.40347e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
5.36115e-05
|
|
|
IPF1
|
[NCBI]
|
5.34193e-05
|
|
|
C1ORF27
|
[NCBI]
|
5.32184e-05
|
|
|
KCNIP2
|
[NCBI]
|
5.32184e-05
|
|
|
C6ORF15
|
[NCBI]
|
5.32184e-05
|
|
|
LRCH1
|
[NCBI]
|
5.32184e-05
|
|
|
EDEM3
|
[NCBI]
|
5.32184e-05
|
|
|
MEX3C
|
[NCBI]
|
5.32184e-05
|
|
|
TBCD
|
[NCBI]
|
5.32184e-05
|
|
|
SFTPA2
|
[NCBI]
|
5.32184e-05
|
|
|
sen15, yeast, homolog of
|
[NCBI]
|
5.32184e-05
|
|
|
ENDOGL1
|
[NCBI]
|
5.32184e-05
|
|
|
COX7B2
|
[NCBI]
|
5.32184e-05
|
|
|
kiaa0319 gene
|
[NCBI]
|
5.32184e-05
|
|
|
MTNR1B
|
[NCBI]
|
5.32184e-05
|
|
|
THBS4
|
[NCBI]
|
5.32184e-05
|
|
|
PRSS16
|
[NCBI]
|
5.32184e-05
|
|
|
dendritic cell nuclear protein 1
|
[NCBI]
|
5.32184e-05
|
|
|
HS6ST3
|
[NCBI]
|
5.32184e-05
|
|
|
KIAA1109
|
[NCBI]
|
5.32184e-05
|
|
|
IFI35
|
[NCBI]
|
5.32184e-05
|
|
|
KCNS3
|
[NCBI]
|
5.32184e-05
|
|
|
HSPA12A
|
[NCBI]
|
5.32184e-05
|
|
|
NPL
|
[NCBI]
|
5.32184e-05
|
|
|
FGF11
|
[NCBI]
|
5.32184e-05
|
|
|
DOCK3
|
[NCBI]
|
5.32184e-05
|
|
|
ZNF79
|
[NCBI]
|
5.32184e-05
|
|
|
CTTNBP2
|
[NCBI]
|
5.32184e-05
|
|
|
MGST3
|
[NCBI]
|
5.32184e-05
|
|
|
GPR35
|
[NCBI]
|
5.32184e-05
|
|
|
GFPT2
|
[NCBI]
|
5.32184e-05
|
|
|
XRCC2
|
[NCBI]
|
5.27516e-05
|
|
|
EN2
|
[NCBI]
|
5.27516e-05
|
|
|
CFI
|
[NCBI]
|
5.27279e-05
|
|
|
AKR1B1
|
[NCBI]
|
5.26634e-05
|
|
|
DRPLA
|
[NCBI]
|
5.26502e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
5.25968e-05
|
|
|
branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal duct, and premature aging
|
[NCBI]
|
5.250567e-05
|
|
|
LEPR
|
[NCBI]
|
5.22745e-05
|
|
|
BUB1B
|
[NCBI]
|
5.21977e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
5.20036e-05
|
|
|
SORBS1
|
[NCBI]
|
5.19595e-05
|
|
|
MTRR
|
[NCBI]
|
5.18483e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
5.15172e-05
|
|
|
SLC22A5
|
[NCBI]
|
5.14199e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
5.12955e-05
|
|
|
TNFRSF25
|
[NCBI]
|
5.12286e-05
|
|
|
MTND3
|
[NCBI]
|
5.071e-05
|
|
|
TPH1
|
[NCBI]
|
5.0551e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
5.02361e-05
|
|
|
PDCD5
|
[NCBI]
|
5.02049e-05
|
|
|
FXYD6
|
[NCBI]
|
5.01968e-05
|
|
|
PDLIM4
|
[NCBI]
|
5.01968e-05
|
|
|
APOL5
|
[NCBI]
|
5.01968e-05
|
|
|
ACCN4
|
[NCBI]
|
5.01968e-05
|
|
|
ADAT1
|
[NCBI]
|
5.01968e-05
|
|
|
RRH
|
[NCBI]
|
5.01968e-05
|
|
|
ZWINT
|
[NCBI]
|
5.01968e-05
|
|
|
APOL6
|
[NCBI]
|
5.01968e-05
|
|
|
ZNF365
|
[NCBI]
|
5.01968e-05
|
|
|
CADPS2
|
[NCBI]
|
5.01968e-05
|
|
|
AKAP10
|
[NCBI]
|
5.01968e-05
|
|
|
MPST
|
[NCBI]
|
5.01968e-05
|
|
|
DZIP1
|
[NCBI]
|
5.01968e-05
|
|
|
USP24
|
[NCBI]
|
5.01968e-05
|
|
|
AGT
|
[NCBI]
|
5.01623e-05
|
|
|
LAM
|
[NCBI]
|
5.00207e-05
|
|
|
CMM
|
[NCBI]
|
4.99855e-05
|
|
|
MDM2
|
[NCBI]
|
4.9731e-05
|
|
|
fabry disease
|
[NCBI]
|
4.9595e-05
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
4.94747e-05
|
|
|
CMTX5
|
[NCBI]
|
4.94747e-05
|
|
|
HOXA1
|
[NCBI]
|
4.93646e-05
|
|
|
PRND
|
[NCBI]
|
4.93646e-05
|
|
|
ODC1
|
[NCBI]
|
4.93418e-05
|
|
|
TNFRSF10A
|
[NCBI]
|
4.88979e-05
|
|
|
IL12RB1
|
[NCBI]
|
4.83184e-05
|
|
|
DNMBP
|
[NCBI]
|
4.82666e-05
|
|
|
ZNF202
|
[NCBI]
|
4.82666e-05
|
|
|
RBBP4
|
[NCBI]
|
4.82666e-05
|
|
|
PTHR2
|
[NCBI]
|
4.82666e-05
|
|
|
RAB11FIP2
|
[NCBI]
|
4.82666e-05
|
|
|
IL1R2
|
[NCBI]
|
4.82666e-05
|
|
|
CLINT1
|
[NCBI]
|
4.82666e-05
|
|
|
OAZ3
|
[NCBI]
|
4.82666e-05
|
|
|
LSP1
|
[NCBI]
|
4.82666e-05
|
|
|
SETMAR
|
[NCBI]
|
4.82666e-05
|
|
|
RPL12
|
[NCBI]
|
4.82666e-05
|
|
|
SPANXB1
|
[NCBI]
|
4.82666e-05
|
|
|
APOL4
|
[NCBI]
|
4.82666e-05
|
|
|
APOL2
|
[NCBI]
|
4.82666e-05
|
|
|
DUSP3
|
[NCBI]
|
4.82666e-05
|
|
|
CYLD
|
[NCBI]
|
4.8261e-05
|
|
|
ABCA4
|
[NCBI]
|
4.78651e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
4.7765e-05
|
|
|
LTA4H
|
[NCBI]
|
4.73718e-05
|
|
|
FHM1
|
[NCBI]
|
4.72336e-05
|
|
|
autoimmune disease
|
[NCBI]
|
4.70105e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
4.70105e-05
|
|
|
HRPT2
|
[NCBI]
|
4.69251e-05
|
|
|
PMS2
|
[NCBI]
|
4.68899e-05
|
|
|
STX12
|
[NCBI]
|
4.68547e-05
|
|
|
SLC20A1
|
[NCBI]
|
4.68547e-05
|
|
|
KIR2DS2
|
[NCBI]
|
4.68547e-05
|
|
|
MGLL
|
[NCBI]
|
4.68547e-05
|
|
|
HSPA6
|
[NCBI]
|
4.68547e-05
|
|
|
CFHR4
|
[NCBI]
|
4.68547e-05
|
|
|
GABRA6
|
[NCBI]
|
4.68547e-05
|
|
|
ZW10
|
[NCBI]
|
4.68547e-05
|
|
|
INSRR
|
[NCBI]
|
4.68547e-05
|
|
|
STAT3
|
[NCBI]
|
4.67863e-05
|
|
|
GNMT
|
[NCBI]
|
4.66257e-05
|
|
|
OLR1
|
[NCBI]
|
4.65087e-05
|
|
|
CYP2D6
|
[NCBI]
|
4.64413e-05
|
|
|
FSHR
|
[NCBI]
|
4.64241e-05
|
|
|
MLC1
|
[NCBI]
|
4.59039e-05
|
|
|
IRF5
|
[NCBI]
|
4.59039e-05
|
|
|
GABRA2
|
[NCBI]
|
4.574813e-05
|
|
|
COPA
|
[NCBI]
|
4.574813e-05
|
|
|
SMG7
|
[NCBI]
|
4.574813e-05
|
|
|
SLC7A1
|
[NCBI]
|
4.574813e-05
|
|
|
MYO10
|
[NCBI]
|
4.574813e-05
|
|
|
MYO9B
|
[NCBI]
|
4.574813e-05
|
|
|
ATP1B1
|
[NCBI]
|
4.574813e-05
|
|
|
TIRAP
|
[NCBI]
|
4.574813e-05
|
|
|
PREP
|
[NCBI]
|
4.574813e-05
|
|
|
COL19A1
|
[NCBI]
|
4.574813e-05
|
|
|
CFL2
|
[NCBI]
|
4.574813e-05
|
|
|
DACH1
|
[NCBI]
|
4.574813e-05
|
|
|
HK3
|
[NCBI]
|
4.574813e-05
|
|
|
SCA1
|
[NCBI]
|
4.54457e-05
|
|
|
LRP8
|
[NCBI]
|
4.532491e-05
|
|
|
GDNF
|
[NCBI]
|
4.51826e-05
|
|
|
PDE4B
|
[NCBI]
|
4.48433e-05
|
|
|
MEOX1
|
[NCBI]
|
4.48433e-05
|
|
|
ROBO2
|
[NCBI]
|
4.48433e-05
|
|
|
MAG
|
[NCBI]
|
4.46516e-05
|
|
|
PCSK1
|
[NCBI]
|
4.43081e-05
|
|
|
SELE
|
[NCBI]
|
4.43081e-05
|
|
|
BAT1
|
[NCBI]
|
4.408184e-05
|
|
|
PRSS1
|
[NCBI]
|
4.40751e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
4.39898e-05
|
|
|
CCND1
|
[NCBI]
|
4.39828e-05
|
|
|
MEIS1
|
[NCBI]
|
4.38077e-05
|
|
|
JPS
|
[NCBI]
|
4.34754e-05
|
|
|
ARMD2
|
[NCBI]
|
4.34633e-05
|
|
|
CMD1G
|
[NCBI]
|
4.34633e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
4.34633e-05
|
|
|
SPG8
|
[NCBI]
|
4.34633e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
4.34633e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
4.34633e-05
|
|
|
CHBL
|
[NCBI]
|
4.34633e-05
|
|
|
CMT4H
|
[NCBI]
|
4.34633e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
4.34633e-05
|
|
|
MRT2
|
[NCBI]
|
4.34633e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
4.34633e-05
|
|
|
cervical cancer
|
[NCBI]
|
4.34633e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
4.34633e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
4.34633e-05
|
|
|
SPG7
|
[NCBI]
|
4.34633e-05
|
|
|
FIDD
|
[NCBI]
|
4.34633e-05
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 1
|
[NCBI]
|
4.34633e-05
|
|
|
ascaris lumbricoides infection, susceptibility to
|
[NCBI]
|
4.34633e-05
|
|
|
SCA13
|
[NCBI]
|
4.34633e-05
|
|
|
spongiform encephalopathy with neuropsychiatric features
|
[NCBI]
|
4.34633e-05
|
|
|
CMT1C
|
[NCBI]
|
4.34633e-05
|
|
|
CYP19A1
|
[NCBI]
|
4.32969e-05
|
|
|
PMP22
|
[NCBI]
|
4.30535e-05
|
|
|
NDRG1
|
[NCBI]
|
4.28611e-05
|
|
|
MAP3K1
|
[NCBI]
|
4.285657e-05
|
|
|
DMD
|
[NCBI]
|
4.28058e-05
|
|
|
CHRNE
|
[NCBI]
|
4.25915e-05
|
|
|
PLAU
|
[NCBI]
|
4.25712e-05
|
|
|
LOR
|
[NCBI]
|
4.25712e-05
|
|
|
MHC2TA
|
[NCBI]
|
4.25712e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
4.24906e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
4.24737e-05
|
|
|
TNFSF10
|
[NCBI]
|
4.2431e-05
|
|
|
CFTD
|
[NCBI]
|
4.24138e-05
|
|
|
NRXN1
|
[NCBI]
|
4.235201e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
4.20171e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
4.18374e-05
|
|
|
CJD
|
[NCBI]
|
4.17557e-05
|
|
|
GATA1
|
[NCBI]
|
4.14883e-05
|
|
|
CYP3A5
|
[NCBI]
|
4.11301e-05
|
|
|
FGFR3
|
[NCBI]
|
4.095791e-05
|
|
|
DYT1
|
[NCBI]
|
4.07613e-05
|
|
|
EV
|
[NCBI]
|
4.05815e-05
|
|
|
APS2
|
[NCBI]
|
4.051195e-05
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
4.051195e-05
|
|
|
DBQD
|
[NCBI]
|
4.051195e-05
|
|
|
hereditary motor and sensory neuropathy vi
|
[NCBI]
|
3.98867e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
3.98867e-05
|
|
|
THBD
|
[NCBI]
|
3.97974e-05
|
|
|
GHRL
|
[NCBI]
|
3.97492e-05
|
|
|
NDUFV3
|
[NCBI]
|
3.96941e-05
|
|
|
PGLYRP3
|
[NCBI]
|
3.96941e-05
|
|
|
AGGF1
|
[NCBI]
|
3.96941e-05
|
|
|
CASC2
|
[NCBI]
|
3.96941e-05
|
|
|
ORAOV1
|
[NCBI]
|
3.96941e-05
|
|
|
TMPRSS11A
|
[NCBI]
|
3.96941e-05
|
|
|
MTATP8
|
[NCBI]
|
3.96941e-05
|
|
|
C6ORF27
|
[NCBI]
|
3.96941e-05
|
|
|
IFI44
|
[NCBI]
|
3.96941e-05
|
|
|
abl interactor 2
|
[NCBI]
|
3.96941e-05
|
|
|
PGLYRP4
|
[NCBI]
|
3.96941e-05
|
|
|
RYR2
|
[NCBI]
|
3.96898e-05
|
|
|
IDE
|
[NCBI]
|
3.9463e-05
|
|
|
BMP15
|
[NCBI]
|
3.943992e-05
|
|
|
FCGR2B
|
[NCBI]
|
3.93706e-05
|
|
|
IL7R
|
[NCBI]
|
3.91665e-05
|
|
|
CTGF
|
[NCBI]
|
3.91334e-05
|
|
|
RECQL3
|
[NCBI]
|
3.9126e-05
|
|
|
HSAN2
|
[NCBI]
|
3.89924e-05
|
|
|
APOF
|
[NCBI]
|
3.889108e-05
|
|
|
SLC7A9
|
[NCBI]
|
3.88393e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
3.86477e-05
|
|
|
LIG4
|
[NCBI]
|
3.86288e-05
|
|
|
ABCC1
|
[NCBI]
|
3.85053e-05
|
|
|
danon disease
|
[NCBI]
|
3.83938e-05
|
|
|
phenylketonuria
|
[NCBI]
|
3.774908e-05
|
|
|
SHFM1
|
[NCBI]
|
3.760272e-05
|
|
|
BHD
|
[NCBI]
|
3.73735e-05
|
|
|
GNB3
|
[NCBI]
|
3.73203e-05
|
|
|
DDC
|
[NCBI]
|
3.728678e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
3.7199e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
3.7199e-05
|
|
|
SDHB
|
[NCBI]
|
3.69845e-05
|
|
|
ATP13A2
|
[NCBI]
|
3.66725e-05
|
|
|
PADI3
|
[NCBI]
|
3.66725e-05
|
|
|
UNC93B1
|
[NCBI]
|
3.66725e-05
|
|
|
HS1BP3
|
[NCBI]
|
3.66725e-05
|
|
|
ERDA1
|
[NCBI]
|
3.66725e-05
|
|
|
TCL6
|
[NCBI]
|
3.66725e-05
|
|
|
RBM17
|
[NCBI]
|
3.66725e-05
|
|
|
TMBIM1
|
[NCBI]
|
3.66725e-05
|
|
|
GPR78
|
[NCBI]
|
3.66725e-05
|
|
|
BARHL1
|
[NCBI]
|
3.66725e-05
|
|
|
KIAA0196
|
[NCBI]
|
3.66725e-05
|
|
|
PADI1
|
[NCBI]
|
3.66725e-05
|
|
|
G6PC3
|
[NCBI]
|
3.66725e-05
|
|
|
HLA-DRB5
|
[NCBI]
|
3.66725e-05
|
|
|
HIBCH
|
[NCBI]
|
3.66725e-05
|
|
|
glutathione s-transferase, omega-1
|
[NCBI]
|
3.66725e-05
|
|
|
TOX3
|
[NCBI]
|
3.66725e-05
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
3.64996e-05
|
|
|
RTT
|
[NCBI]
|
3.64857e-05
|
|
|
MCP
|
[NCBI]
|
3.63404e-05
|
|
|
PLIN
|
[NCBI]
|
3.63069e-05
|
|
|
ABCC8
|
[NCBI]
|
3.57444e-05
|
|
|
VHL
|
[NCBI]
|
3.56445e-05
|
|
|
PGL3
|
[NCBI]
|
3.56208e-05
|
|
|
AH
|
[NCBI]
|
3.56208e-05
|
|
|
KRS
|
[NCBI]
|
3.56208e-05
|
|
|
AVSD2
|
[NCBI]
|
3.56208e-05
|
|
|
DLB
|
[NCBI]
|
3.52759e-05
|
|
|
IL6R
|
[NCBI]
|
3.50865e-05
|
|
|
PRX
|
[NCBI]
|
3.48991e-05
|
|
|
CFHR5
|
[NCBI]
|
3.47423e-05
|
|
|
LIPH
|
[NCBI]
|
3.47423e-05
|
|
|
OSR2
|
[NCBI]
|
3.47423e-05
|
|
|
APBB2
|
[NCBI]
|
3.47423e-05
|
|
|
NBR1
|
[NCBI]
|
3.47423e-05
|
|
|
TSNAX
|
[NCBI]
|
3.47423e-05
|
|
|
IFNA17
|
[NCBI]
|
3.47423e-05
|
|
|
CTDP1
|
[NCBI]
|
3.47423e-05
|
|
|
POU6F2
|
[NCBI]
|
3.47423e-05
|
|
|
ITPR3
|
[NCBI]
|
3.47423e-05
|
|
|
RSPO1
|
[NCBI]
|
3.47423e-05
|
|
|
SH2D2A
|
[NCBI]
|
3.47423e-05
|
|
|
CHGB
|
[NCBI]
|
3.47423e-05
|
|
|
CD72
|
[NCBI]
|
3.47423e-05
|
|
|
LRMP
|
[NCBI]
|
3.47423e-05
|
|
|
CH25H
|
[NCBI]
|
3.47423e-05
|
|
|
INPP1
|
[NCBI]
|
3.47423e-05
|
|
|
CDK4
|
[NCBI]
|
3.46835e-05
|
|
|
NS1
|
[NCBI]
|
3.46176e-05
|
|
|
BMPR2
|
[NCBI]
|
3.41682e-05
|
|
|
CYP2A6
|
[NCBI]
|
3.406552e-05
|
|
|
PYY
|
[NCBI]
|
3.3867e-05
|
|
|
ALK
|
[NCBI]
|
3.38006e-05
|
|
|
SPINK1
|
[NCBI]
|
3.366394e-05
|
|
|
DCX
|
[NCBI]
|
3.35248e-05
|
|
|
ALOX5
|
[NCBI]
|
3.34906e-05
|
|
|
AARS
|
[NCBI]
|
3.33304e-05
|
|
|
KARS
|
[NCBI]
|
3.33304e-05
|
|
|
RGS8
|
[NCBI]
|
3.33304e-05
|
|
|
FGF13
|
[NCBI]
|
3.33304e-05
|
|
|
PMP2
|
[NCBI]
|
3.33304e-05
|
|
|
NFKBIL1
|
[NCBI]
|
3.33304e-05
|
|
|
MTUS1
|
[NCBI]
|
3.33304e-05
|
|
|
MYH3
|
[NCBI]
|
3.33304e-05
|
|
|
LRRFIP1
|
[NCBI]
|
3.33304e-05
|
|
|
SORCS1
|
[NCBI]
|
3.33304e-05
|
|
|
NMNAT2
|
[NCBI]
|
3.33304e-05
|
|
|
CSTA
|
[NCBI]
|
3.33304e-05
|
|
|
APOL3
|
[NCBI]
|
3.33304e-05
|
|
|
SLC25A12
|
[NCBI]
|
3.33304e-05
|
|
|
LMF1
|
[NCBI]
|
3.33304e-05
|
|
|
NLRP1
|
[NCBI]
|
3.33304e-05
|
|
|
TCF7
|
[NCBI]
|
3.33304e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
3.33304e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
3.30972e-05
|
|
|
GPI
|
[NCBI]
|
3.30807e-05
|
|
|
SPR
|
[NCBI]
|
3.3056e-05
|
|
|
IL13
|
[NCBI]
|
3.30535e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.30313e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
3.29485e-05
|
|
|
GEFS+
|
[NCBI]
|
3.27306e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.2562e-05
|
|
|
SPCH1
|
[NCBI]
|
3.24187e-05
|
|
|
MCOPS1
|
[NCBI]
|
3.23933e-05
|
|
|
CCM2
|
[NCBI]
|
3.23831e-05
|
|
|
PLA2G2A
|
[NCBI]
|
3.22709e-05
|
|
|
PCDH8
|
[NCBI]
|
3.222383e-05
|
|
|
SYN2
|
[NCBI]
|
3.222383e-05
|
|
|
PADI4
|
[NCBI]
|
3.222383e-05
|
|
|
NPY5R
|
[NCBI]
|
3.222383e-05
|
|
|
HTR7
|
[NCBI]
|
3.222383e-05
|
|
|
TACR2
|
[NCBI]
|
3.222383e-05
|
|
|
P2RX4
|
[NCBI]
|
3.222383e-05
|
|
|
MLX
|
[NCBI]
|
3.222383e-05
|
|
|
KALRN
|
[NCBI]
|
3.222383e-05
|
|
|
SLC9A3R1
|
[NCBI]
|
3.222383e-05
|
|
|
PVRL2
|
[NCBI]
|
3.222383e-05
|
|
|
KIR2DL2
|
[NCBI]
|
3.222383e-05
|
|
|
MTF1
|
[NCBI]
|
3.222383e-05
|
|
|
KMO
|
[NCBI]
|
3.222383e-05
|
|
|
CCNG1
|
[NCBI]
|
3.222383e-05
|
|
|
GDF1
|
[NCBI]
|
3.222383e-05
|
|
|
TGFB1
|
[NCBI]
|
3.1932e-05
|
|
|
OR51E1
|
[NCBI]
|
3.17275e-05
|
|
|
STOX1
|
[NCBI]
|
3.17275e-05
|
|
|
MTTA
|
[NCBI]
|
3.17275e-05
|
|
|
MTTQ
|
[NCBI]
|
3.17275e-05
|
|
|
ALG9
|
[NCBI]
|
3.17275e-05
|
|
|
fshd gene 2
|
[NCBI]
|
3.17275e-05
|
|
|
PDCD10
|
[NCBI]
|
3.17275e-05
|
|
|
FLT4
|
[NCBI]
|
3.17176e-05
|
|
|
BFLS
|
[NCBI]
|
3.14952e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
3.13714e-05
|
|
|
CTNNA2
|
[NCBI]
|
3.1319e-05
|
|
|
AXIN1
|
[NCBI]
|
3.1319e-05
|
|
|
APOL1
|
[NCBI]
|
3.1319e-05
|
|
|
HSD11B1
|
[NCBI]
|
3.11981e-05
|
|
|
IL12A
|
[NCBI]
|
3.0731e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
3.06811e-05
|
|
|
NN
|
[NCBI]
|
3.06811e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
3.06811e-05
|
|
|
ovarian cancer, epithelial
|
[NCBI]
|
3.06811e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
3.067612e-05
|
|
|
CCL2
|
[NCBI]
|
3.06464e-05
|
|
|
HCRT
|
[NCBI]
|
3.06145e-05
|
|
|
KSR1
|
[NCBI]
|
3.055754e-05
|
|
|
ADAM15
|
[NCBI]
|
3.055754e-05
|
|
|
IFNAR2
|
[NCBI]
|
3.055754e-05
|
|
|
CYP4A11
|
[NCBI]
|
3.055754e-05
|
|
|
IFNGR2
|
[NCBI]
|
3.055754e-05
|
|
|
RXRG
|
[NCBI]
|
3.055754e-05
|
|
|
ME1
|
[NCBI]
|
3.055754e-05
|
|
|
acromegaly
|
[NCBI]
|
3.05058e-05
|
|
|
HYPX
|
[NCBI]
|
3.036478e-05
|
|
|
PLOSL
|
[NCBI]
|
3.01228e-05
|
|
|
TP53
|
[NCBI]
|
3.00213e-05
|
|
|
SLC2A8
|
[NCBI]
|
2.99033e-05
|
|
|
SOD3
|
[NCBI]
|
2.99033e-05
|
|
|
NOTCH4
|
[NCBI]
|
2.99033e-05
|
|
|
MYLK
|
[NCBI]
|
2.99033e-05
|
|
|
CCL3L1
|
[NCBI]
|
2.99033e-05
|
|
|
WRN
|
[NCBI]
|
2.98749e-05
|
|
|
MFS
|
[NCBI]
|
2.98029e-05
|
|
|
RGS5
|
[NCBI]
|
2.97973e-05
|
|
|
SLC6A14
|
[NCBI]
|
2.97973e-05
|
|
|
FBXO31
|
[NCBI]
|
2.97973e-05
|
|
|
ITPKC
|
[NCBI]
|
2.97973e-05
|
|
|
CTNNA3
|
[NCBI]
|
2.97973e-05
|
|
|
SLITRK1
|
[NCBI]
|
2.97973e-05
|
|
|
NKX3A
|
[NCBI]
|
2.97973e-05
|
|
|
CBFA2T3
|
[NCBI]
|
2.97973e-05
|
|
|
GPD1L
|
[NCBI]
|
2.97973e-05
|
|
|
SMYD3
|
[NCBI]
|
2.97973e-05
|
|
|
HPS3
|
[NCBI]
|
2.97973e-05
|
|
|
PCM1
|
[NCBI]
|
2.97973e-05
|
|
|
GPNMB
|
[NCBI]
|
2.97973e-05
|
|
|
ZNF81
|
[NCBI]
|
2.97973e-05
|
|
|
AXIN2
|
[NCBI]
|
2.97973e-05
|
|
|
MUS81
|
[NCBI]
|
2.97973e-05
|
|
|
DFNB10
|
[NCBI]
|
2.96384e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
2.96384e-05
|
|
|
MRXSL
|
[NCBI]
|
2.96384e-05
|
|
|
DFNB8
|
[NCBI]
|
2.96384e-05
|
|
|
ARVD2
|
[NCBI]
|
2.96384e-05
|
|
|
DFNA20
|
[NCBI]
|
2.96384e-05
|
|
|
fumarase deficiency
|
[NCBI]
|
2.96384e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
2.961135e-05
|
|
|
DMD
|
[NCBI]
|
2.937948e-05
|
|
|
PCSK2
|
[NCBI]
|
2.933227e-05
|
|
|
SLC29A1
|
[NCBI]
|
2.933227e-05
|
|
|
VCL
|
[NCBI]
|
2.933227e-05
|
|
|
SLC30A3
|
[NCBI]
|
2.933227e-05
|
|
|
FAAH
|
[NCBI]
|
2.921708e-05
|
|
|
GAL
|
[NCBI]
|
2.911846e-05
|
|
|
SCA10
|
[NCBI]
|
2.89776e-05
|
|
|
AIRE
|
[NCBI]
|
2.88784e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
2.88767e-05
|
|
|
BLM
|
[NCBI]
|
2.840358e-05
|
|
|
PTGDR
|
[NCBI]
|
2.83854e-05
|
|
|
SART1
|
[NCBI]
|
2.83854e-05
|
|
|
KCNC3
|
[NCBI]
|
2.83854e-05
|
|
|
FADS1
|
[NCBI]
|
2.83854e-05
|
|
|
MX1
|
[NCBI]
|
2.83854e-05
|
|
|
TRIM5
|
[NCBI]
|
2.83854e-05
|
|
|
IRAK3
|
[NCBI]
|
2.83854e-05
|
|
|
CCL24
|
[NCBI]
|
2.83854e-05
|
|
|
TRIM21
|
[NCBI]
|
2.83854e-05
|
|
|
MYBL2
|
[NCBI]
|
2.83854e-05
|
|
|
LGALS2
|
[NCBI]
|
2.83854e-05
|
|
|
POSTN
|
[NCBI]
|
2.83854e-05
|
|
|
GDF6
|
[NCBI]
|
2.83854e-05
|
|
|
PACRG
|
[NCBI]
|
2.83854e-05
|
|
|
IFIT1
|
[NCBI]
|
2.83854e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.8317e-05
|
|
|
CMD1A
|
[NCBI]
|
2.82996e-05
|
|
|
GJA5
|
[NCBI]
|
2.826451e-05
|
|
|
IRF1
|
[NCBI]
|
2.81729e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.816475e-05
|
|
|
VWS
|
[NCBI]
|
2.80425e-05
|
|
|
EA2
|
[NCBI]
|
2.80084e-05
|
|
|
GTS
|
[NCBI]
|
2.799667e-05
|
|
|
KIR3DL1
|
[NCBI]
|
2.797251e-05
|
|
|
DPP4
|
[NCBI]
|
2.797251e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
2.794279e-05
|
|
|
ORW2
|
[NCBI]
|
2.79138e-05
|
|
|
longevity
|
[NCBI]
|
2.767459e-05
|
|
|
TNFRSF6
|
[NCBI]
|
2.76256e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.74434e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
2.74434e-05
|
|
|
NFKB1
|
[NCBI]
|
2.738081e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.73633e-05
|
|
|
KIR2DL3
|
[NCBI]
|
2.727883e-05
|
|
|
CD24
|
[NCBI]
|
2.727883e-05
|
|
|
PLA2G1B
|
[NCBI]
|
2.727883e-05
|
|
|
CMA1
|
[NCBI]
|
2.727883e-05
|
|
|
MMP10
|
[NCBI]
|
2.727883e-05
|
|
|
DGKD
|
[NCBI]
|
2.727883e-05
|
|
|
NLGN4
|
[NCBI]
|
2.727883e-05
|
|
|
CASP12
|
[NCBI]
|
2.727883e-05
|
|
|
TNNT3
|
[NCBI]
|
2.727883e-05
|
|
|
NOD1
|
[NCBI]
|
2.727883e-05
|
|
|
CNTN4
|
[NCBI]
|
2.727883e-05
|
|
|
ZFPM1
|
[NCBI]
|
2.727883e-05
|
|
|
PCTT
|
[NCBI]
|
2.7273e-05
|
|
|
ETF1
|
[NCBI]
|
2.727186e-05
|
|
|
LPL
|
[NCBI]
|
2.69206e-05
|
|
|
BBS
|
[NCBI]
|
2.67977e-05
|
|
|
CUL1
|
[NCBI]
|
2.668562e-05
|
|
|
BST1
|
[NCBI]
|
2.66759e-05
|
|
|
SCA17
|
[NCBI]
|
2.6653e-05
|
|
|
RETN
|
[NCBI]
|
2.65203e-05
|
|
|
CACNA2D1
|
[NCBI]
|
2.6374e-05
|
|
|
NFIA
|
[NCBI]
|
2.6374e-05
|
|
|
CCR1
|
[NCBI]
|
2.6374e-05
|
|
|
AIF1
|
[NCBI]
|
2.6374e-05
|
|
|
ABO
|
[NCBI]
|
2.632238e-05
|
|
|
BSG
|
[NCBI]
|
2.63036e-05
|
|
|
VWM
|
[NCBI]
|
2.5707e-05
|
|
|
MRT1
|
[NCBI]
|
2.5639e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
2.5639e-05
|
|
|
MMP1
|
[NCBI]
|
2.56324e-05
|
|
|
NLGN3
|
[NCBI]
|
2.561254e-05
|
|
|
PTGIR
|
[NCBI]
|
2.561254e-05
|
|
|
S100B
|
[NCBI]
|
2.561254e-05
|
|
|
ADORA1
|
[NCBI]
|
2.561254e-05
|
|
|
ROBO1
|
[NCBI]
|
2.561254e-05
|
|
|
APBB1
|
[NCBI]
|
2.561254e-05
|
|
|
LOXL1
|
[NCBI]
|
2.561254e-05
|
|
|
PODXL
|
[NCBI]
|
2.561254e-05
|
|
|
PANK2
|
[NCBI]
|
2.5326e-05
|
|
|
OR51E2
|
[NCBI]
|
2.5264e-05
|
|
|
CCM2
|
[NCBI]
|
2.5264e-05
|
|
|
EHF
|
[NCBI]
|
2.5264e-05
|
|
|
FAM20C
|
[NCBI]
|
2.5264e-05
|
|
|
ITM2B
|
[NCBI]
|
2.5264e-05
|
|
|
SH3TC2
|
[NCBI]
|
2.5264e-05
|
|
|
CHI3L1
|
[NCBI]
|
2.5264e-05
|
|
|
CDH6
|
[NCBI]
|
2.5264e-05
|
|
|
VAPB
|
[NCBI]
|
2.5264e-05
|
|
|
CD2AP
|
[NCBI]
|
2.525949e-05
|
|
|
PROCR
|
[NCBI]
|
2.518932e-05
|
|
|
CLEC7A
|
[NCBI]
|
2.49583e-05
|
|
|
NTS
|
[NCBI]
|
2.49583e-05
|
|
|
HOMER1
|
[NCBI]
|
2.49583e-05
|
|
|
SEMA7A
|
[NCBI]
|
2.49583e-05
|
|
|
GNAL
|
[NCBI]
|
2.49583e-05
|
|
|
HRH1
|
[NCBI]
|
2.49583e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
2.48851e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
2.48851e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.48851e-05
|
|
|
NEM2
|
[NCBI]
|
2.48851e-05
|
|
|
CCM3
|
[NCBI]
|
2.48851e-05
|
|
|
HGPPS
|
[NCBI]
|
2.48851e-05
|
|
|
valproate embryopathy, susceptibility to
|
[NCBI]
|
2.48851e-05
|
|
|
WT5
|
[NCBI]
|
2.48851e-05
|
|
|
CZP3
|
[NCBI]
|
2.48851e-05
|
|
|
ABCB11
|
[NCBI]
|
2.479347e-05
|
|
|
KL
|
[NCBI]
|
2.455735e-05
|
|
|
HFE
|
[NCBI]
|
2.449966e-05
|
|
|
MEN2A
|
[NCBI]
|
2.43988e-05
|
|
|
CR2
|
[NCBI]
|
2.438727e-05
|
|
|
TSPY
|
[NCBI]
|
2.438727e-05
|
|
|
CYP2E
|
[NCBI]
|
2.438727e-05
|
|
|
TLR9
|
[NCBI]
|
2.433751e-05
|
|
|
HLA-DRA
|
[NCBI]
|
2.418743e-05
|
|
|
PON3
|
[NCBI]
|
2.415743e-05
|
|
|
STX11
|
[NCBI]
|
2.415743e-05
|
|
|
CDY1
|
[NCBI]
|
2.415743e-05
|
|
|
GLI2
|
[NCBI]
|
2.415743e-05
|
|
|
PVOD
|
[NCBI]
|
2.412675e-05
|
|
|
CTSS
|
[NCBI]
|
2.388271e-05
|
|
|
OAS1
|
[NCBI]
|
2.388271e-05
|
|
|
RGS4
|
[NCBI]
|
2.388271e-05
|
|
|
PDCD2
|
[NCBI]
|
2.388271e-05
|
|
|
HTR1B
|
[NCBI]
|
2.388271e-05
|
|
|
KCNMB1
|
[NCBI]
|
2.388271e-05
|
|
|
IRS1
|
[NCBI]
|
2.371679e-05
|
|
|
HLA-A
|
[NCBI]
|
2.358886e-05
|
|
|
OPMD
|
[NCBI]
|
2.34401e-05
|
|
|
GABBR2
|
[NCBI]
|
2.343249e-05
|
|
|
KIR2DL1
|
[NCBI]
|
2.343249e-05
|
|
|
CDKN1C
|
[NCBI]
|
2.342512e-05
|
|
|
MUC3A
|
[NCBI]
|
2.32526e-05
|
|
|
SUFU
|
[NCBI]
|
2.32526e-05
|
|
|
PDLIM3
|
[NCBI]
|
2.32526e-05
|
|
|
BRD2
|
[NCBI]
|
2.32526e-05
|
|
|
CDKN2C
|
[NCBI]
|
2.32526e-05
|
|
|
FABP4
|
[NCBI]
|
2.32526e-05
|
|
|
CTS1
|
[NCBI]
|
2.32504e-05
|
|
|
BWS
|
[NCBI]
|
2.314841e-05
|
|
|
CLN6
|
[NCBI]
|
2.30807e-05
|
|
|
frontonasal dysplasia
|
[NCBI]
|
2.30807e-05
|
|
|
MPD1
|
[NCBI]
|
2.30807e-05
|
|
|
CDG1C
|
[NCBI]
|
2.30807e-05
|
|
|
FSGS1
|
[NCBI]
|
2.30807e-05
|
|
|
SELL
|
[NCBI]
|
2.302751e-05
|
|
|
CVID
|
[NCBI]
|
2.301131e-05
|
|
|
SNCAIP
|
[NCBI]
|
2.30087e-05
|
|
|
saitohin
|
[NCBI]
|
2.30087e-05
|
|
|
PHF6
|
[NCBI]
|
2.30087e-05
|
|
|
TTR
|
[NCBI]
|
2.291348e-05
|
|
|
SANDO
|
[NCBI]
|
2.28095e-05
|
|
|
NPAS2
|
[NCBI]
|
2.26608e-05
|
|
|
IL10RB
|
[NCBI]
|
2.249114e-05
|
|
|
TRPM7
|
[NCBI]
|
2.249114e-05
|
|
|
HSD17B1
|
[NCBI]
|
2.249114e-05
|
|
|
CENPJ
|
[NCBI]
|
2.249114e-05
|
|
|
HMMR
|
[NCBI]
|
2.249114e-05
|
|
|
CETP
|
[NCBI]
|
2.238294e-05
|
|
|
IGKC
|
[NCBI]
|
2.229692e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
2.216096e-05
|
|
|
PMS1
|
[NCBI]
|
2.190213e-05
|
|
|
PLG
|
[NCBI]
|
2.185044e-05
|
|
|
GCKR
|
[NCBI]
|
2.18369e-05
|
|
|
EDNRA
|
[NCBI]
|
2.18369e-05
|
|
|
HEY2
|
[NCBI]
|
2.18369e-05
|
|
|
TNF
|
[NCBI]
|
2.179072e-05
|
|
|
ITGB3
|
[NCBI]
|
2.175598e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
2.173687e-05
|
|
|
WFS1
|
[NCBI]
|
2.16434e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.160152e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
2.156845e-05
|
|
|
PEDF
|
[NCBI]
|
2.151742e-05
|
|
|
APRT
|
[NCBI]
|
2.138418e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.1372784e-05
|
|
|
HDC
|
[NCBI]
|
2.12012e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
2.117948e-05
|
|
|
FGF9
|
[NCBI]
|
2.102064e-05
|
|
|
JBTS3
|
[NCBI]
|
2.10051e-05
|
|
|
ODG2
|
[NCBI]
|
2.10051e-05
|
|
|
MDC1C
|
[NCBI]
|
2.10051e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
2.10051e-05
|
|
|
ACTN4
|
[NCBI]
|
2.09973e-05
|
|
|
P2RY12
|
[NCBI]
|
2.09973e-05
|
|
|
SATB2
|
[NCBI]
|
2.09973e-05
|
|
|
NHLH1
|
[NCBI]
|
2.09973e-05
|
|
|
KCNE3
|
[NCBI]
|
2.09973e-05
|
|
|
PSNP1
|
[NCBI]
|
2.08444e-05
|
|
|
TNFSF12
|
[NCBI]
|
2.076131e-05
|
|
|
TRAF1
|
[NCBI]
|
2.076131e-05
|
|
|
STXBP1
|
[NCBI]
|
2.076131e-05
|
|
|
BAG4
|
[NCBI]
|
2.076131e-05
|
|
|
LAMC1
|
[NCBI]
|
2.076131e-05
|
|
|
GATA2
|
[NCBI]
|
2.076131e-05
|
|
|
NPTX2
|
[NCBI]
|
2.076131e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
2.074144e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
2.074124e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.06704e-05
|
|
|
RMD
|
[NCBI]
|
2.066326e-05
|
|
|
SCN1A
|
[NCBI]
|
2.045782e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
2.045571e-05
|
|
|
PTCH1
|
[NCBI]
|
2.042745e-05
|
|
|
LTK
|
[NCBI]
|
2.031109e-05
|
|
|
PBX1
|
[NCBI]
|
2.023584e-05
|
|
|
VKORC1
|
[NCBI]
|
2.023584e-05
|
|
|
PSTPIP1
|
[NCBI]
|
2.023584e-05
|
|
|
HAVCR2
|
[NCBI]
|
2.023584e-05
|
|
|
OGFR
|
[NCBI]
|
2.023584e-05
|
|
|
SLC3A1
|
[NCBI]
|
2.02054e-05
|
|
|
RBP4
|
[NCBI]
|
2.020438e-05
|
|
|
HSN2
|
[NCBI]
|
2.015693e-05
|
|
|
GJC2
|
[NCBI]
|
2.015693e-05
|
|
|
KCNE2
|
[NCBI]
|
2.015693e-05
|
|
|
HMCN1
|
[NCBI]
|
2.015693e-05
|
|
|
MTTH
|
[NCBI]
|
2.015693e-05
|
|
|
MPO
|
[NCBI]
|
1.998879e-05
|
|
|
CACNA1A
|
[NCBI]
|
1.997695e-05
|
|
|
KRT18
|
[NCBI]
|
1.990611e-05
|
|
|
PTPRC
|
[NCBI]
|
1.978668e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.974268e-05
|
|
|
MTND5
|
[NCBI]
|
1.964294e-05
|
|
|
ST7
|
[NCBI]
|
1.95816e-05
|
|
|
SIPA1
|
[NCBI]
|
1.95816e-05
|
|
|
ABCA2
|
[NCBI]
|
1.95816e-05
|
|
|
SDC3
|
[NCBI]
|
1.95816e-05
|
|
|
ABCG8
|
[NCBI]
|
1.95816e-05
|
|
|
GAB2
|
[NCBI]
|
1.95816e-05
|
|
|
DNASE1
|
[NCBI]
|
1.95816e-05
|
|
|
NPHP2
|
[NCBI]
|
1.949285e-05
|
|
|
MCKD2
|
[NCBI]
|
1.949285e-05
|
|
|
vitiligo
|
[NCBI]
|
1.949285e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
1.929065e-05
|
|
|
CCL7
|
[NCBI]
|
1.92521e-05
|
|
|
TRMU
|
[NCBI]
|
1.92521e-05
|
|
|
VPS13A
|
[NCBI]
|
1.92521e-05
|
|
|
DGCR14
|
[NCBI]
|
1.92521e-05
|
|
|
MMP8
|
[NCBI]
|
1.92521e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
1.92521e-05
|
|
|
PPP1R3A
|
[NCBI]
|
1.92521e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
1.92521e-05
|
|
|
HOKPP
|
[NCBI]
|
1.910543e-05
|
|
|
TYK2
|
[NCBI]
|
1.901057e-05
|
|
|
HAS1
|
[NCBI]
|
1.901057e-05
|
|
|
TNNI2
|
[NCBI]
|
1.901057e-05
|
|
|
ADRB2
|
[NCBI]
|
1.896718e-05
|
|
|
TMPO
|
[NCBI]
|
1.889992e-05
|
|
|
CPB2
|
[NCBI]
|
1.863208e-05
|
|
|
BCNS
|
[NCBI]
|
1.86255e-05
|
|
|
POLD1
|
[NCBI]
|
1.861922e-05
|
|
|
JBTS1
|
[NCBI]
|
1.857023e-05
|
|
|
CHH
|
[NCBI]
|
1.854602e-05
|
|
|
LRP6
|
[NCBI]
|
1.850601e-05
|
|
|
SMAD7
|
[NCBI]
|
1.850601e-05
|
|
|
RBBP8
|
[NCBI]
|
1.850601e-05
|
|
|
GAS6
|
[NCBI]
|
1.850601e-05
|
|
|
TAC1
|
[NCBI]
|
1.849064e-05
|
|
|
SNCB
|
[NCBI]
|
1.849064e-05
|
|
|
CLCN2
|
[NCBI]
|
1.849064e-05
|
|
|
CHMP2B
|
[NCBI]
|
1.849064e-05
|
|
|
IL2RA
|
[NCBI]
|
1.846164e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
1.845039e-05
|
|
|
DHS
|
[NCBI]
|
1.842337e-05
|
|
|
WBS
|
[NCBI]
|
1.836987e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
1.820735e-05
|
|
|
char syndrome
|
[NCBI]
|
1.820735e-05
|
|
|
JK
|
[NCBI]
|
1.812113e-05
|
|
|
Ge
|
[NCBI]
|
1.812113e-05
|
|
|
SMA2
|
[NCBI]
|
1.810797e-05
|
|
|
PCD
|
[NCBI]
|
1.809295e-05
|
|
|
MATN1
|
[NCBI]
|
1.805579e-05
|
|
|
MMP9
|
[NCBI]
|
1.80434e-05
|
|
|
FUT2
|
[NCBI]
|
1.789924e-05
|
|
|
PER2
|
[NCBI]
|
1.789924e-05
|
|
|
HRPT2
|
[NCBI]
|
1.784403e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.784403e-05
|
|
|
VLDLRCH
|
[NCBI]
|
1.77784e-05
|
|
|
EDM4
|
[NCBI]
|
1.77784e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.77784e-05
|
|
|
SPG10
|
[NCBI]
|
1.77784e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
1.77784e-05
|
|
|
NPHP3
|
[NCBI]
|
1.77784e-05
|
|
|
CMT2D
|
[NCBI]
|
1.77784e-05
|
|
|
SCA12
|
[NCBI]
|
1.77784e-05
|
|
|
ACVRL1
|
[NCBI]
|
1.760265e-05
|
|
|
SMAD4
|
[NCBI]
|
1.731611e-05
|
|
|
FCGR2A
|
[NCBI]
|
1.72841e-05
|
|
|
GABRA1
|
[NCBI]
|
1.72841e-05
|
|
|
DRD1
|
[NCBI]
|
1.72841e-05
|
|
|
EDAR
|
[NCBI]
|
1.726537e-05
|
|
|
ICSBP1
|
[NCBI]
|
1.726537e-05
|
|
|
CD3E
|
[NCBI]
|
1.726537e-05
|
|
|
SMARCA3
|
[NCBI]
|
1.726537e-05
|
|
|
SLC22A18
|
[NCBI]
|
1.726537e-05
|
|
|
OPLL
|
[NCBI]
|
1.710297e-05
|
|
|
NOS3
|
[NCBI]
|
1.709858e-05
|
|
|
S100A7
|
[NCBI]
|
1.708257e-05
|
|
|
DCLRE1C
|
[NCBI]
|
1.708257e-05
|
|
|
CD40LG
|
[NCBI]
|
1.704701e-05
|
|
|
EKV
|
[NCBI]
|
1.698313e-05
|
|
|
AURKA
|
[NCBI]
|
1.695016e-05
|
|
|
CDK5
|
[NCBI]
|
1.68997e-05
|
|
|
DEFB4
|
[NCBI]
|
1.676081e-05
|
|
|
TNFSF4
|
[NCBI]
|
1.676081e-05
|
|
|
KERA
|
[NCBI]
|
1.676081e-05
|
|
|
INSR
|
[NCBI]
|
1.673686e-05
|
|
|
MB
|
[NCBI]
|
1.672994e-05
|
|
|
APOA2
|
[NCBI]
|
1.664462e-05
|
|
|
ALPS
|
[NCBI]
|
1.654814e-05
|
|
|
FTD3
|
[NCBI]
|
1.64929e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
1.64929e-05
|
|
|
ARHGEF6
|
[NCBI]
|
1.642833e-05
|
|
|
NFE2L2
|
[NCBI]
|
1.642833e-05
|
|
|
UCP3
|
[NCBI]
|
1.639493e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
1.634414e-05
|
|
|
MSH3
|
[NCBI]
|
1.631059e-05
|
|
|
H19
|
[NCBI]
|
1.62115e-05
|
|
|
CFNS
|
[NCBI]
|
1.621137e-05
|
|
|
PEMT
|
[NCBI]
|
1.619138e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
1.614665e-05
|
|
|
CALM1
|
[NCBI]
|
1.610514e-05
|
|
|
GJA1
|
[NCBI]
|
1.597636e-05
|
|
|
PVR
|
[NCBI]
|
1.596703e-05
|
|
|
LPIN2
|
[NCBI]
|
1.591405e-05
|
|
|
XBP1
|
[NCBI]
|
1.590561e-05
|
|
|
PKM2
|
[NCBI]
|
1.590561e-05
|
|
|
POF1
|
[NCBI]
|
1.586238e-05
|
|
|
AGC1
|
[NCBI]
|
1.58573e-05
|
|
|
LITAF
|
[NCBI]
|
1.58573e-05
|
|
|
SCNN1G
|
[NCBI]
|
1.58573e-05
|
|
|
PTGER2
|
[NCBI]
|
1.58573e-05
|
|
|
ZIC2
|
[NCBI]
|
1.58573e-05
|
|
|
UCP2
|
[NCBI]
|
1.585429e-05
|
|
|
FY
|
[NCBI]
|
1.577892e-05
|
|
|
GCH1
|
[NCBI]
|
1.574245e-05
|
|
|
INCENP
|
[NCBI]
|
1.5722696e-05
|
|
|
CAV3
|
[NCBI]
|
1.556205e-05
|
|
|
ATP1A1
|
[NCBI]
|
1.55389e-05
|
|
|
TCF4
|
[NCBI]
|
1.55389e-05
|
|
|
COL9A1
|
[NCBI]
|
1.55389e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
1.538852e-05
|
|
|
SBS
|
[NCBI]
|
1.538852e-05
|
|
|
NEUROD1
|
[NCBI]
|
1.535274e-05
|
|
|
TREM2
|
[NCBI]
|
1.535274e-05
|
|
|
T
|
[NCBI]
|
1.535274e-05
|
|
|
TGIF
|
[NCBI]
|
1.535274e-05
|
|
|
EBS-MP
|
[NCBI]
|
1.531361e-05
|
|
|
AHI1
|
[NCBI]
|
1.525981e-05
|
|
|
SST
|
[NCBI]
|
1.51486e-05
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
1.513374e-05
|
|
|
AANAT
|
[NCBI]
|
1.5070575e-05
|
|
|
HFE4
|
[NCBI]
|
1.505864e-05
|
|
|
PCS
|
[NCBI]
|
1.505864e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.500061e-05
|
|
|
PGR
|
[NCBI]
|
1.49061227e-05
|
|
|
SOAT1
|
[NCBI]
|
1.490252e-05
|
|
|
PON2
|
[NCBI]
|
1.490252e-05
|
|
|
TBX21
|
[NCBI]
|
1.489942e-05
|
|
|
NTF3
|
[NCBI]
|
1.489942e-05
|
|
|
POU5F1
|
[NCBI]
|
1.489942e-05
|
|
|
DYT1
|
[NCBI]
|
1.485541e-05
|
|
|
IL23A
|
[NCBI]
|
1.483576e-05
|
|
|
DYX1
|
[NCBI]
|
1.479083e-05
|
|
|
SCO2
|
[NCBI]
|
1.468878e-05
|
|
|
TLR1
|
[NCBI]
|
1.461872e-05
|
|
|
down syndrome
|
[NCBI]
|
1.460737e-05
|
|
|
MCOPS2
|
[NCBI]
|
1.458483e-05
|
|
|
MPZ
|
[NCBI]
|
1.457329e-05
|
|
|
constricting bands, congenital
|
[NCBI]
|
1.455567e-05
|
|
|
IL8RB
|
[NCBI]
|
1.449754e-05
|
|
|
CDC25A
|
[NCBI]
|
1.449754e-05
|
|
|
ICOS
|
[NCBI]
|
1.449754e-05
|
|
|
PRDX5
|
[NCBI]
|
1.449754e-05
|
|
|
RA
|
[NCBI]
|
1.433928e-05
|
|
|
DDB2
|
[NCBI]
|
1.427042e-05
|
|
|
DFNA5
|
[NCBI]
|
1.427042e-05
|
|
|
OCP
|
[NCBI]
|
1.42247e-05
|
|
|
BARD1
|
[NCBI]
|
1.418422e-05
|
|
|
PTPRO
|
[NCBI]
|
1.418422e-05
|
|
|
CFD
|
[NCBI]
|
1.418422e-05
|
|
|
DYSF
|
[NCBI]
|
1.414123e-05
|
|
|
DAZL
|
[NCBI]
|
1.413083e-05
|
|
|
ACTG1
|
[NCBI]
|
1.413083e-05
|
|
|
SREBF1
|
[NCBI]
|
1.412063e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
1.412063e-05
|
|
|
BCHE
|
[NCBI]
|
1.4119635e-05
|
|
|
LIS1
|
[NCBI]
|
1.410633e-05
|
|
|
pseudotrisomy 13 syndrome
|
[NCBI]
|
1.395426e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
1.395426e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
1.395426e-05
|
|
|
USH1D
|
[NCBI]
|
1.395426e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
1.395426e-05
|
|
|
AT
|
[NCBI]
|
1.39094e-05
|
|
|
BDA1
|
[NCBI]
|
1.384824e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
1.384824e-05
|
|
|
P2RX7
|
[NCBI]
|
1.379689e-05
|
|
|
neuroblastoma
|
[NCBI]
|
1.374511e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.3734e-05
|
|
|
RECQL4
|
[NCBI]
|
1.369939e-05
|
|
|
HOS
|
[NCBI]
|
1.36965e-05
|
|
|
TYMS
|
[NCBI]
|
1.3690714e-05
|
|
|
RNS
|
[NCBI]
|
1.359916e-05
|
|
|
OTSC1
|
[NCBI]
|
1.34506e-05
|
|
|
CSF2
|
[NCBI]
|
1.341961e-05
|
|
|
EPD
|
[NCBI]
|
1.338328e-05
|
|
|
MATN3
|
[NCBI]
|
1.332902e-05
|
|
|
SIX1
|
[NCBI]
|
1.332902e-05
|
|
|
SIX3
|
[NCBI]
|
1.332902e-05
|
|
|
EBF
|
[NCBI]
|
1.332137e-05
|
|
|
HNFJ
|
[NCBI]
|
1.325774e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.321065e-05
|
|
|
SEMA3B
|
[NCBI]
|
1.319483e-05
|
|
|
AAAS
|
[NCBI]
|
1.319483e-05
|
|
|
POMGNT1
|
[NCBI]
|
1.319483e-05
|
|
|
schwannomatosis
|
[NCBI]
|
1.299794e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
1.299794e-05
|
|
|
MTHFD1
|
[NCBI]
|
1.296231e-05
|
|
|
AQP7
|
[NCBI]
|
1.296231e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.284903e-05
|
|
|
APP
|
[NCBI]
|
1.280133e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
1.27703e-05
|
|
|
BOR1
|
[NCBI]
|
1.275404e-05
|
|
|
GNPAT
|
[NCBI]
|
1.274461e-05
|
|
|
CILP
|
[NCBI]
|
1.274461e-05
|
|
|
BFSP2
|
[NCBI]
|
1.274461e-05
|
|
|
UBQLN1
|
[NCBI]
|
1.274461e-05
|
|
|
gracile syndrome
|
[NCBI]
|
1.274386e-05
|
|
|
OSMED
|
[NCBI]
|
1.274386e-05
|
|
|
SCA14
|
[NCBI]
|
1.274386e-05
|
|
|
JAK2
|
[NCBI]
|
1.273722e-05
|
|
|
MTND2
|
[NCBI]
|
1.271328e-05
|
|
|
IL6ST
|
[NCBI]
|
1.271256e-05
|
|
|
ACY1
|
[NCBI]
|
1.271256e-05
|
|
|
musical perfect pitch
|
[NCBI]
|
1.26952524e-05
|
|
|
OGG1
|
[NCBI]
|
1.262837e-05
|
|
|
aortic valve disease
|
[NCBI]
|
1.261043e-05
|
|
|
AMC
|
[NCBI]
|
1.246727e-05
|
|
|
WT1
|
[NCBI]
|
1.234946e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.233963e-05
|
|
|
KRT8
|
[NCBI]
|
1.233963e-05
|
|
|
DRD5
|
[NCBI]
|
1.232283e-05
|
|
|
IFNA1
|
[NCBI]
|
1.22287e-05
|
|
|
hydrocephalus
|
[NCBI]
|
1.21649e-05
|
|
|
CDC25C
|
[NCBI]
|
1.204213e-05
|
|
|
SCARB1
|
[NCBI]
|
1.204213e-05
|
|
|
C5R1
|
[NCBI]
|
1.197292e-05
|
|
|
RASSF1
|
[NCBI]
|
1.197292e-05
|
|
|
DUOX2
|
[NCBI]
|
1.197292e-05
|
|
|
HNPP
|
[NCBI]
|
1.193643e-05
|
|
|
LDLR
|
[NCBI]
|
1.18004e-05
|
|
|
RAD51
|
[NCBI]
|
1.178335e-05
|
|
|
PEG3
|
[NCBI]
|
1.178335e-05
|
|
|
HD
|
[NCBI]
|
1.1726142e-05
|
|
|
EFNB1
|
[NCBI]
|
1.163898e-05
|
|
|
CLEC4M
|
[NCBI]
|
1.163898e-05
|
|
|
SGCG
|
[NCBI]
|
1.160519e-05
|
|
|
HSR
|
[NCBI]
|
1.158936e-05
|
|
|
F2RL1
|
[NCBI]
|
1.154404e-05
|
|
|
VCAM1
|
[NCBI]
|
1.154404e-05
|
|
|
RECK
|
[NCBI]
|
1.148927e-05
|
|
|
RMRP
|
[NCBI]
|
1.148927e-05
|
|
|
ADD1
|
[NCBI]
|
1.148927e-05
|
|
|
CD209
|
[NCBI]
|
1.148927e-05
|
|
|
HCHWAD
|
[NCBI]
|
1.143612e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.133344e-05
|
|
|
SHH
|
[NCBI]
|
1.1330504e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.115497e-05
|
|
|
SCN8A
|
[NCBI]
|
1.115497e-05
|
|
|
ECGF1
|
[NCBI]
|
1.115497e-05
|
|
|
TPMT
|
[NCBI]
|
1.111513e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.105274e-05
|
|
|
PIGR
|
[NCBI]
|
1.0985424e-05
|
|
|
GINGF
|
[NCBI]
|
1.09545e-05
|
|
|
CASR
|
[NCBI]
|
1.093883e-05
|
|
|
EPHB2
|
[NCBI]
|
1.092392e-05
|
|
|
TBP
|
[NCBI]
|
1.08624658e-05
|
|
|
BMP2
|
[NCBI]
|
1.085594e-05
|
|
|
GABRG2
|
[NCBI]
|
1.079396e-05
|
|
|
DCTN1
|
[NCBI]
|
1.078862e-05
|
|
|
IL6
|
[NCBI]
|
1.076273e-05
|
|
|
MTC
|
[NCBI]
|
1.076013e-05
|
|
|
SMDP1
|
[NCBI]
|
1.076013e-05
|
|
|
CMT2B
|
[NCBI]
|
1.076013e-05
|
|
|
CRYGC
|
[NCBI]
|
1.074999e-05
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
1.074999e-05
|
|
|
NF2
|
[NCBI]
|
1.070932e-05
|
|
|
BRRS
|
[NCBI]
|
1.06699e-05
|
|
|
ADSL
|
[NCBI]
|
1.055465e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.055465e-05
|
|
|
CCKAR
|
[NCBI]
|
1.048308e-05
|
|
|
GRA
|
[NCBI]
|
1.044693e-05
|
|
|
SOD1
|
[NCBI]
|
1.042596e-05
|
|
|
DSG1
|
[NCBI]
|
1.040386e-05
|
|
|
CEP290
|
[NCBI]
|
1.038328e-05
|
|
|
BLMH
|
[NCBI]
|
1.038328e-05
|
|
|
EBI3
|
[NCBI]
|
1.038328e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.025887e-05
|
|
|
ADRB1
|
[NCBI]
|
1.020238e-05
|
|
|
GGH
|
[NCBI]
|
1.004934e-05
|
|
|
MTMR2
|
[NCBI]
|
1.004934e-05
|
|
|
CD14
|
[NCBI]
|
1.004934e-05
|
|
|
TSC2
|
[NCBI]
|
9.99509e-06
|
|
|
LEP
|
[NCBI]
|
9.95903e-06
|
|
|
SCNN1A
|
[NCBI]
|
9.9436e-06
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
9.92709e-06
|
|
|
INPP5D
|
[NCBI]
|
9.88654e-06
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
9.88508e-06
|
|
|
SCA7
|
[NCBI]
|
9.749e-06
|
|
|
ENAM
|
[NCBI]
|
9.7438e-06
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
9.74018e-06
|
|
|
NCF2
|
[NCBI]
|
9.73479e-06
|
|
|
PDP
|
[NCBI]
|
9.73262e-06
|
|
|
PTEN
|
[NCBI]
|
9.72391e-06
|
|
|
ACTA1
|
[NCBI]
|
9.70429e-06
|
|
|
CCM
|
[NCBI]
|
9.58812e-06
|
|
|
RHD
|
[NCBI]
|
9.58803e-06
|
|
|
KDR
|
[NCBI]
|
9.48518e-06
|
|
|
FGF3
|
[NCBI]
|
9.4824e-06
|
|
|
CNR1
|
[NCBI]
|
9.4631e-06
|
|
|
COL4A1
|
[NCBI]
|
9.43145e-06
|
|
|
PARK2
|
[NCBI]
|
9.41512e-06
|
|
|
NOTCH3
|
[NCBI]
|
9.40085e-06
|
|
|
FCMD
|
[NCBI]
|
9.35285e-06
|
|
|
REN
|
[NCBI]
|
9.31837e-06
|
|
|
NETH
|
[NCBI]
|
9.30551e-06
|
|
|
erythermalgia, primary
|
[NCBI]
|
9.30551e-06
|
|
|
GALK1
|
[NCBI]
|
9.27619e-06
|
|
|
APOM
|
[NCBI]
|
9.20432e-06
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
9.19831e-06
|
|
|
SFTPC
|
[NCBI]
|
9.1619e-06
|
|
|
EIF2B5
|
[NCBI]
|
9.1619e-06
|
|
|
HTR2A
|
[NCBI]
|
9.1473e-06
|
|
|
CACNA1C
|
[NCBI]
|
9.1473e-06
|
|
|
FOXP2
|
[NCBI]
|
9.09531e-06
|
|
|
CMT2A1
|
[NCBI]
|
9.05204e-06
|
|
|
adult syndrome
|
[NCBI]
|
9.05204e-06
|
|
|
LGI1
|
[NCBI]
|
9.01965e-06
|
|
|
NOS1
|
[NCBI]
|
9.01829e-06
|
|
|
BHMT
|
[NCBI]
|
8.96501e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
8.96488e-06
|
|
|
GHSR
|
[NCBI]
|
8.90503e-06
|
|
|
ASIP
|
[NCBI]
|
8.90503e-06
|
|
|
DSG2
|
[NCBI]
|
8.82796e-06
|
|
|
CYBA
|
[NCBI]
|
8.81461e-06
|
|
|
COL18A1
|
[NCBI]
|
8.81461e-06
|
|
|
TRAF2
|
[NCBI]
|
8.74148e-06
|
|
|
OPA1
|
[NCBI]
|
8.7229e-06
|
|
|
GRIN1
|
[NCBI]
|
8.57583e-06
|
|
|
IHPS1
|
[NCBI]
|
8.55884e-06
|
|
|
FGB
|
[NCBI]
|
8.55583e-06
|
|
|
DAO
|
[NCBI]
|
8.445196e-06
|
|
|
GSK3B
|
[NCBI]
|
8.43443e-06
|
|
|
PTGS1
|
[NCBI]
|
8.34489e-06
|
|
|
NM
|
[NCBI]
|
8.32326e-06
|
|
|
GJA3
|
[NCBI]
|
8.31652e-06
|
|
|
LGMD1B
|
[NCBI]
|
8.30585e-06
|
|
|
LQT3
|
[NCBI]
|
8.30585e-06
|
|
|
LGMD2I
|
[NCBI]
|
8.30585e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
8.30585e-06
|
|
|
BMPR1A
|
[NCBI]
|
8.24172e-06
|
|
|
MCOLN1
|
[NCBI]
|
8.19874e-06
|
|
|
SALL4
|
[NCBI]
|
8.15871e-06
|
|
|
ABL
|
[NCBI]
|
8.13052e-06
|
|
|
FLNA
|
[NCBI]
|
8.11159e-06
|
|
|
myeloma, multiple
|
[NCBI]
|
8.09511e-06
|
|
|
DRRS
|
[NCBI]
|
8.09511e-06
|
|
|
IRDN
|
[NCBI]
|
8.09463e-06
|
|
|
homocystinuria
|
[NCBI]
|
8.02418e-06
|
|
|
CRYGD
|
[NCBI]
|
7.8648e-06
|
|
|
KRT9
|
[NCBI]
|
7.792e-06
|
|
|
GJB2
|
[NCBI]
|
7.753833e-06
|
|
|
ATP1A2
|
[NCBI]
|
7.73276e-06
|
|
|
hemophilia a
|
[NCBI]
|
7.686678e-06
|
|
|
OPD1
|
[NCBI]
|
7.68379e-06
|
|
|
LGMD2A
|
[NCBI]
|
7.67278e-06
|
|
|
GCCR
|
[NCBI]
|
7.60874e-06
|
|
|
HMN5
|
[NCBI]
|
7.57707e-06
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
7.57707e-06
|
|
|
GDAP1
|
[NCBI]
|
7.55926e-06
|
|
|
SPG3A
|
[NCBI]
|
7.55926e-06
|
|
|
LMX1B
|
[NCBI]
|
7.52174e-06
|
|
|
IL9
|
[NCBI]
|
7.52174e-06
|
|
|
KCNE1
|
[NCBI]
|
7.52174e-06
|
|
|
COL11A1
|
[NCBI]
|
7.47398e-06
|
|
|
AHO
|
[NCBI]
|
7.46548e-06
|
|
|
TSC1
|
[NCBI]
|
7.43824e-06
|
|
|
CD4
|
[NCBI]
|
7.42865e-06
|
|
|
RSTS
|
[NCBI]
|
7.42585e-06
|
|
|
WM1
|
[NCBI]
|
7.380391e-06
|
|
|
CCNE1
|
[NCBI]
|
7.31553e-06
|
|
|
sotos syndrome
|
[NCBI]
|
7.27191e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
7.23578e-06
|
|
|
HAE
|
[NCBI]
|
7.23047e-06
|
|
|
FCAS
|
[NCBI]
|
7.22985e-06
|
|
|
IHH
|
[NCBI]
|
7.21202e-06
|
|
|
APEX
|
[NCBI]
|
7.19371e-06
|
|
|
PKHD1
|
[NCBI]
|
7.15252e-06
|
|
|
SIX5
|
[NCBI]
|
7.15252e-06
|
|
|
CUBN
|
[NCBI]
|
7.12351e-06
|
|
|
COL11A2
|
[NCBI]
|
7.01278e-06
|
|
|
MMP12
|
[NCBI]
|
7.01278e-06
|
|
|
kaposi sarcoma
|
[NCBI]
|
6.9376e-06
|
|
|
AHR
|
[NCBI]
|
6.911584e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
6.90329e-06
|
|
|
SH2D1A
|
[NCBI]
|
6.85118e-06
|
|
|
CSF1
|
[NCBI]
|
6.80657e-06
|
|
|
TSG101
|
[NCBI]
|
6.78016e-06
|
|
|
ACCN2
|
[NCBI]
|
6.640468e-06
|
|
|
XFS
|
[NCBI]
|
6.62732e-06
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
6.62732e-06
|
|
|
CHRNA1
|
[NCBI]
|
6.61455e-06
|
|
|
SLC6A8
|
[NCBI]
|
6.55858e-06
|
|
|
PCDH15
|
[NCBI]
|
6.55858e-06
|
|
|
CADASIL
|
[NCBI]
|
6.46648e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
6.37552e-06
|
|
|
GLRA1
|
[NCBI]
|
6.37373e-06
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
6.36029e-06
|
|
|
CACNA1S
|
[NCBI]
|
6.35237e-06
|
|
|
NNMT
|
[NCBI]
|
6.35237e-06
|
|
|
LMS
|
[NCBI]
|
6.3018e-06
|
|
|
LGMD2B
|
[NCBI]
|
6.3018e-06
|
|
|
esophageal cancer
|
[NCBI]
|
6.3018e-06
|
|
|
ADLTE
|
[NCBI]
|
6.3018e-06
|
|
|
CTSB
|
[NCBI]
|
6.26805e-06
|
|
|
NSD1
|
[NCBI]
|
6.24781e-06
|
|
|
A2M
|
[NCBI]
|
6.21552e-06
|
|
|
FGFR1
|
[NCBI]
|
6.20093e-06
|
|
|
EDM1
|
[NCBI]
|
6.19265e-06
|
|
|
amyloidosis v
|
[NCBI]
|
6.19265e-06
|
|
|
NME1
|
[NCBI]
|
6.16035e-06
|
|
|
TF
|
[NCBI]
|
6.12601e-06
|
|
|
MM
|
[NCBI]
|
6.12103e-06
|
|
|
MEB
|
[NCBI]
|
6.10106e-06
|
|
|
NF1
|
[NCBI]
|
6.09639e-06
|
|
|
RHS
|
[NCBI]
|
6.06055e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
6.01188e-06
|
|
|
PDGFRA
|
[NCBI]
|
5.98121e-06
|
|
|
BTK
|
[NCBI]
|
5.980843e-06
|
|
|
ERCC6
|
[NCBI]
|
5.94563e-06
|
|
|
OPD2
|
[NCBI]
|
5.88113e-06
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
5.88113e-06
|
|
|
LWD
|
[NCBI]
|
5.81493e-06
|
|
|
NKX2-1
|
[NCBI]
|
5.81385e-06
|
|
|
NR3C2
|
[NCBI]
|
5.81385e-06
|
|
|
ADRB3
|
[NCBI]
|
5.78661e-06
|
|
|
H6PD
|
[NCBI]
|
5.7837294e-06
|
|
|
GC
|
[NCBI]
|
5.68919e-06
|
|
|
SPG7
|
[NCBI]
|
5.67988e-06
|
|
|
GCK
|
[NCBI]
|
5.65338e-06
|
|
|
MME
|
[NCBI]
|
5.5804e-06
|
|
|
CRMO
|
[NCBI]
|
5.5753792e-06
|
|
|
AMPD1
|
[NCBI]
|
5.57447e-06
|
|
|
SCP2
|
[NCBI]
|
5.560938e-06
|
|
|
SPP1
|
[NCBI]
|
5.527024e-06
|
|
|
GBA
|
[NCBI]
|
5.52298e-06
|
|
|
SAA1
|
[NCBI]
|
5.497704e-06
|
|
|
NR1I2
|
[NCBI]
|
5.477894e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
5.47691e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
5.46337e-06
|
|
|
PRKCG
|
[NCBI]
|
5.45799e-06
|
|
|
SLC2A1
|
[NCBI]
|
5.38838e-06
|
|
|
GLDC
|
[NCBI]
|
5.38381e-06
|
|
|
ABCG2
|
[NCBI]
|
5.37437e-06
|
|
|
ELA2
|
[NCBI]
|
5.37312e-06
|
|
|
ESR1
|
[NCBI]
|
5.3691e-06
|
|
|
RASA1
|
[NCBI]
|
5.32397e-06
|
|
|
JMML
|
[NCBI]
|
5.2932e-06
|
|
|
PPARGC1A
|
[NCBI]
|
5.24411e-06
|
|
|
PTPN1
|
[NCBI]
|
5.24411e-06
|
|
|
ATF6
|
[NCBI]
|
5.24411e-06
|
|
|
SDS
|
[NCBI]
|
5.14607e-06
|
|
|
MITF
|
[NCBI]
|
5.10559e-06
|
|
|
LPG
|
[NCBI]
|
5.06485e-06
|
|
|
HAMP
|
[NCBI]
|
5.05976e-06
|
|
|
TIMP1
|
[NCBI]
|
5.00917e-06
|
|
|
DMBT1
|
[NCBI]
|
4.95571e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
4.95571e-06
|
|
|
POAG
|
[NCBI]
|
4.94973e-06
|
|
|
UCP1
|
[NCBI]
|
4.92778e-06
|
|
|
SGCE
|
[NCBI]
|
4.89495e-06
|
|
|
FRAXE
|
[NCBI]
|
4.89495e-06
|
|
|
MSX1
|
[NCBI]
|
4.8853e-06
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
4.81066e-06
|
|
|
PPCD1
|
[NCBI]
|
4.81066e-06
|
|
|
STAT4
|
[NCBI]
|
4.80165e-06
|
|
|
MYH7
|
[NCBI]
|
4.78215e-06
|
|
|
CRP
|
[NCBI]
|
4.73864e-06
|
|
|
SLC12A3
|
[NCBI]
|
4.73864e-06
|
|
|
HRAS
|
[NCBI]
|
4.71745e-06
|
|
|
GPX1
|
[NCBI]
|
4.71623e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
4.67921e-06
|
|
|
ASL
|
[NCBI]
|
4.52600983e-06
|
|
|
AGS1
|
[NCBI]
|
4.43931e-06
|
|
|
MCPH1
|
[NCBI]
|
4.42905e-06
|
|
|
JH
|
[NCBI]
|
4.42905e-06
|
|
|
PLP1
|
[NCBI]
|
4.41095e-06
|
|
|
DKC1
|
[NCBI]
|
4.31758e-06
|
|
|
FXTAS
|
[NCBI]
|
4.24868e-06
|
|
|
EEC3
|
[NCBI]
|
4.24868e-06
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
4.24868e-06
|
|
|
KCNQ1
|
[NCBI]
|
4.22131e-06
|
|
|
CYP1B1
|
[NCBI]
|
4.15022e-06
|
|
|
CTSK
|
[NCBI]
|
4.14352e-06
|
|
|
EGR2
|
[NCBI]
|
4.11395e-06
|
|
|
SOST
|
[NCBI]
|
4.09492e-06
|
|
|
COMP
|
[NCBI]
|
4.0826188e-06
|
|
|
ADAMTS13
|
[NCBI]
|
4.07682e-06
|
|
|
FMO3
|
[NCBI]
|
4.049188e-06
|
|
|
CDH23
|
[NCBI]
|
3.99364e-06
|
|
|
CYP11B1
|
[NCBI]
|
3.99364e-06
|
|
|
costello syndrome
|
[NCBI]
|
3.961009e-06
|
|
|
KCNH2
|
[NCBI]
|
3.93904e-06
|
|
|
HPS
|
[NCBI]
|
3.87278e-06
|
|
|
CYP1A1
|
[NCBI]
|
3.84108308e-06
|
|
|
SCCMS
|
[NCBI]
|
3.81401e-06
|
|
|
AGER
|
[NCBI]
|
3.808013e-06
|
|
|
MEN1
|
[NCBI]
|
3.7572208e-06
|
|
|
MECP2
|
[NCBI]
|
3.712942e-06
|
|
|
FMR1
|
[NCBI]
|
3.695078e-06
|
|
|
PKD2
|
[NCBI]
|
3.64366e-06
|
|
|
PPS
|
[NCBI]
|
3.627216e-06
|
|
|
LRP5
|
[NCBI]
|
3.60622e-06
|
|
|
COL1A2
|
[NCBI]
|
3.594156e-06
|
|
|
FGF2
|
[NCBI]
|
3.580097e-06
|
|
|
alexander disease
|
[NCBI]
|
3.55476e-06
|
|
|
SCA2
|
[NCBI]
|
3.549947e-06
|
|
|
NF2
|
[NCBI]
|
3.54464e-06
|
|
|
EMD
|
[NCBI]
|
3.53581e-06
|
|
|
MAP3K5
|
[NCBI]
|
3.52427e-06
|
|
|
APTX
|
[NCBI]
|
3.49686e-06
|
|
|
HYPP
|
[NCBI]
|
3.48364e-06
|
|
|
CPI
|
[NCBI]
|
3.46704e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
3.43132e-06
|
|
|
CDG1A
|
[NCBI]
|
3.41641e-06
|
|
|
PMCH
|
[NCBI]
|
3.401629e-06
|
|
|
AVSD
|
[NCBI]
|
3.40142e-06
|
|
|
PPARA
|
[NCBI]
|
3.38703e-06
|
|
|
COL2A1
|
[NCBI]
|
3.364995e-06
|
|
|
CRYAB
|
[NCBI]
|
3.33972e-06
|
|
|
EYA1
|
[NCBI]
|
3.33972e-06
|
|
|
MVK
|
[NCBI]
|
3.33972e-06
|
|
|
VHL
|
[NCBI]
|
3.338591e-06
|
|
|
FEB1
|
[NCBI]
|
3.3256845e-06
|
|
|
SDHD
|
[NCBI]
|
3.321e-06
|
|
|
GJB3
|
[NCBI]
|
3.321e-06
|
|
|
IPEX
|
[NCBI]
|
3.26335e-06
|
|
|
LIFR
|
[NCBI]
|
3.252918e-06
|
|
|
TTN
|
[NCBI]
|
3.23858e-06
|
|
|
CHGA
|
[NCBI]
|
3.23858e-06
|
|
|
KRAS
|
[NCBI]
|
3.195933e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.183313872e-06
|
|
|
GRB2
|
[NCBI]
|
3.146947723e-06
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
3.09827e-06
|
|
|
CDK6
|
[NCBI]
|
3.059268e-06
|
|
|
GAN1
|
[NCBI]
|
2.991416e-06
|
|
|
SLC25A4
|
[NCBI]
|
2.88771e-06
|
|
|
SPG2
|
[NCBI]
|
2.80686e-06
|
|
|
MET
|
[NCBI]
|
2.8027e-06
|
|
|
GSD
|
[NCBI]
|
2.792965e-06
|
|
|
PTX3
|
[NCBI]
|
2.78075e-06
|
|
|
C4A
|
[NCBI]
|
2.754712e-06
|
|
|
VLDLR
|
[NCBI]
|
2.719514e-06
|
|
|
MCKD1
|
[NCBI]
|
2.7112745e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.696783e-06
|
|
|
DBI
|
[NCBI]
|
2.68466e-06
|
|
|
HHT
|
[NCBI]
|
2.6713209e-06
|
|
|
WFS1
|
[NCBI]
|
2.65254e-06
|
|
|
TYR
|
[NCBI]
|
2.643952e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
2.630154e-06
|
|
|
PAM
|
[NCBI]
|
2.5956e-06
|
|
|
FGFR2
|
[NCBI]
|
2.584982e-06
|
|
|
CFB
|
[NCBI]
|
2.560174e-06
|
|
|
FKRP
|
[NCBI]
|
2.480955e-06
|
|
|
ASPS
|
[NCBI]
|
2.451256e-06
|
|
|
bladder cancer
|
[NCBI]
|
2.42417e-06
|
|
|
TTDP
|
[NCBI]
|
2.398488e-06
|
|
|
FTL
|
[NCBI]
|
2.3901e-06
|
|
|
TFF1
|
[NCBI]
|
2.358482e-06
|
|
|
COL1A1
|
[NCBI]
|
2.347786e-06
|
|
|
TTP
|
[NCBI]
|
2.322148e-06
|
|
|
TERC
|
[NCBI]
|
2.30117e-06
|
|
|
TP73L
|
[NCBI]
|
2.251522e-06
|
|
|
LBR
|
[NCBI]
|
2.2007121e-06
|
|
|
IRS2
|
[NCBI]
|
2.150962e-06
|
|
|
GCE
|
[NCBI]
|
2.136974e-06
|
|
|
SVAS
|
[NCBI]
|
2.122503e-06
|
|
|
meningioma, familial
|
[NCBI]
|
2.11784e-06
|
|
|
CBAVD
|
[NCBI]
|
2.107078e-06
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
2.044593e-06
|
|
|
C1NH
|
[NCBI]
|
1.979515e-06
|
|
|
TSHR
|
[NCBI]
|
1.968769e-06
|
|
|
RARA
|
[NCBI]
|
1.963078e-06
|
|
|
DURS1
|
[NCBI]
|
1.951953703e-06
|
|
|
FGA
|
[NCBI]
|
1.940054e-06
|
|
|
RB1
|
[NCBI]
|
1.93958e-06
|
|
|
FGG
|
[NCBI]
|
1.930433e-06
|
|
|
PI
|
[NCBI]
|
1.909705e-06
|
|
|
DCT
|
[NCBI]
|
1.883154e-06
|
|
|
LRP1
|
[NCBI]
|
1.869105e-06
|
|
|
PHA
|
[NCBI]
|
1.865658e-06
|
|
|
CLN2
|
[NCBI]
|
1.854322e-06
|
|
|
brugada syndrome 1
|
[NCBI]
|
1.854322e-06
|
|
|
PPIA
|
[NCBI]
|
1.824713e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.8119e-06
|
|
|
DSG3
|
[NCBI]
|
1.772166e-06
|
|
|
DNMT1
|
[NCBI]
|
1.758097e-06
|
|
|
ACADS
|
[NCBI]
|
1.754573e-06
|
|
|
RDT
|
[NCBI]
|
1.753331e-06
|
|
|
LCT
|
[NCBI]
|
1.743923e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
1.733214374e-06
|
|
|
PGL1
|
[NCBI]
|
1.721009e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.717517e-06
|
|
|
FFI
|
[NCBI]
|
1.681221e-06
|
|
|
CSTB
|
[NCBI]
|
1.673383e-06
|
|
|
RSMD1
|
[NCBI]
|
1.6406963e-06
|
|
|
FOXO1A
|
[NCBI]
|
1.596735e-06
|
|
|
CMT1A
|
[NCBI]
|
1.55989e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.5534194e-06
|
|
|
CAPN3
|
[NCBI]
|
1.492463e-06
|
|
|
NEM3
|
[NCBI]
|
1.48736078e-06
|
|
|
CMTX1
|
[NCBI]
|
1.480081e-06
|
|
|
GDF5
|
[NCBI]
|
1.464153e-06
|
|
|
HIDS
|
[NCBI]
|
1.451139e-06
|
|
|
CCL17
|
[NCBI]
|
1.44702259e-06
|
|
|
GH1
|
[NCBI]
|
1.443383e-06
|
|
|
NBS1
|
[NCBI]
|
1.426273e-06
|
|
|
IL18
|
[NCBI]
|
1.417536e-06
|
|
|
EDMD2
|
[NCBI]
|
1.390288e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.378274e-06
|
|
|
LI1
|
[NCBI]
|
1.35751e-06
|
|
|
SLC1A2
|
[NCBI]
|
1.336951e-06
|
|
|
PPOX
|
[NCBI]
|
1.327661e-06
|
|
|
IKBKG
|
[NCBI]
|
1.327661e-06
|
|
|
FBN1
|
[NCBI]
|
1.326754e-06
|
|
|
TBS
|
[NCBI]
|
1.325073e-06
|
|
|
MEFV
|
[NCBI]
|
1.299105e-06
|
|
|
NR0B2
|
[NCBI]
|
1.2932046e-06
|
|
|
PML
|
[NCBI]
|
1.264377e-06
|
|
|
CLL
|
[NCBI]
|
1.255871e-06
|
|
|
MTS
|
[NCBI]
|
1.2480351e-06
|
|
|
RBP1
|
[NCBI]
|
1.2198267e-06
|
|
|
SCD
|
[NCBI]
|
1.211025e-06
|
|
|
SPG3A
|
[NCBI]
|
1.206415e-06
|
|
|
AAA
|
[NCBI]
|
1.19272e-06
|
|
|
PLTP
|
[NCBI]
|
1.125204e-06
|
|
|
KAL2
|
[NCBI]
|
1.061732e-06
|
|
|
FGF1
|
[NCBI]
|
1.052155e-06
|
|
|
GSN
|
[NCBI]
|
1.047943e-06
|
|
|
MYH11
|
[NCBI]
|
1.045506e-06
|
|
|
FHIT
|
[NCBI]
|
1.028253e-06
|
|
|
MDC1A
|
[NCBI]
|
1.014813e-06
|
|
|
UCMD
|
[NCBI]
|
9.87105e-07
|
|
|
APL
|
[NCBI]
|
9.87105e-07
|
|
|
DM2
|
[NCBI]
|
9.7816e-07
|
|
|
cystinuria
|
[NCBI]
|
9.3206e-07
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
9.0782742e-07
|
|
|
APS1
|
[NCBI]
|
8.99557e-07
|
|
|
NPHP1
|
[NCBI]
|
8.815507e-07
|
|
|
RTS
|
[NCBI]
|
8.64397e-07
|
|
|
AKT1
|
[NCBI]
|
8.12032e-07
|
|
|
LCAT
|
[NCBI]
|
8.116093e-07
|
|
|
XPA
|
[NCBI]
|
7.94656e-07
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
7.8717578e-07
|
|
|
PKLR
|
[NCBI]
|
7.75107e-07
|
|
|
GAMT
|
[NCBI]
|
7.75107e-07
|
|
|
NR5A1
|
[NCBI]
|
7.745604e-07
|
|
|
HNF4A
|
[NCBI]
|
7.6634894e-07
|
|
|
CNC1
|
[NCBI]
|
7.22734e-07
|
|
|
SLC26A4
|
[NCBI]
|
6.9932242e-07
|
|
|
CFTR
|
[NCBI]
|
6.878766e-07
|
|
|
KAL1
|
[NCBI]
|
6.83117e-07
|
|
|
DA2A
|
[NCBI]
|
6.824953e-07
|
|
|
AMACR
|
[NCBI]
|
6.50552e-07
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
6.400602e-07
|
|
|
PLN
|
[NCBI]
|
6.26954e-07
|
|
|
MEN2B
|
[NCBI]
|
6.115738e-07
|
|
|
CD
|
[NCBI]
|
6.03984e-07
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
5.98707423e-07
|
|
|
RHO
|
[NCBI]
|
5.862597e-07
|
|
|
WT1
|
[NCBI]
|
5.8201894e-07
|
|
|
LIPC
|
[NCBI]
|
5.8114529e-07
|
|
|
PPT1
|
[NCBI]
|
5.8078942e-07
|
|
|
PG
|
[NCBI]
|
5.72123e-07
|
|
|
DES
|
[NCBI]
|
5.589195e-07
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
5.58683e-07
|
|
|
SMA1
|
[NCBI]
|
5.485208e-07
|
|
|
GAA
|
[NCBI]
|
5.362042e-07
|
|
|
ACADM
|
[NCBI]
|
5.29644e-07
|
|
|
ABCA1
|
[NCBI]
|
4.9799e-07
|
|
|
CREBBP
|
[NCBI]
|
4.9799e-07
|
|
|
CLU
|
[NCBI]
|
4.8562e-07
|
|
|
TFR2
|
[NCBI]
|
4.616685e-07
|
|
|
CGL2
|
[NCBI]
|
4.571015e-07
|
|
|
DAZ
|
[NCBI]
|
4.47317e-07
|
|
|
APOB
|
[NCBI]
|
4.46739e-07
|
|
|
CHAC
|
[NCBI]
|
4.44561e-07
|
|
|
FOLH1
|
[NCBI]
|
4.420052e-07
|
|
|
MLC
|
[NCBI]
|
4.29575e-07
|
|
|
CLN1
|
[NCBI]
|
4.29575e-07
|
|
|
MADA
|
[NCBI]
|
4.29575e-07
|
|
|
LGMD2C
|
[NCBI]
|
4.110398e-07
|
|
|
DMPK
|
[NCBI]
|
4.09604e-07
|
|
|
LQT1
|
[NCBI]
|
4.08029e-07
|
|
|
IL3
|
[NCBI]
|
4.076452e-07
|
|
|
pfeiffer syndrome
|
[NCBI]
|
4.059588e-07
|
|
|
CYP17A1
|
[NCBI]
|
4.045692e-07
|
|
|
HRG
|
[NCBI]
|
3.80822e-07
|
|
|
ABCB1
|
[NCBI]
|
3.49638e-07
|
|
|
ALAD
|
[NCBI]
|
3.4953e-07
|
|
|
ERBB2
|
[NCBI]
|
3.34777e-07
|
|
|
BIRC1
|
[NCBI]
|
3.2492736e-07
|
|
|
TERT
|
[NCBI]
|
2.988365e-07
|
|
|
AQP2
|
[NCBI]
|
2.969891e-07
|
|
|
neural tube defects
|
[NCBI]
|
2.874764e-07
|
|
|
ATF3
|
[NCBI]
|
2.7329583e-07
|
|
|
FOXP3
|
[NCBI]
|
2.7128636e-07
|
|
|
MTM1
|
[NCBI]
|
2.708765e-07
|
|
|
F2
|
[NCBI]
|
2.53253e-07
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
2.481128e-07
|
|
|
DRD
|
[NCBI]
|
2.44401e-07
|
|
|
APCS
|
[NCBI]
|
2.4387916e-07
|
|
|
STGD1
|
[NCBI]
|
2.278305e-07
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.229834e-07
|
|
|
glycogen storage disease v
|
[NCBI]
|
1.861602e-07
|
|
|
MC4R
|
[NCBI]
|
1.808484e-07
|
|
|
OPTB1
|
[NCBI]
|
1.52026e-07
|
|
|
MMP2
|
[NCBI]
|
1.35346723e-07
|
|
|
MHA
|
[NCBI]
|
1.3118478e-07
|
|
|
PSAP
|
[NCBI]
|
1.248592e-07
|
|
|
DAR
|
[NCBI]
|
1.239678e-07
|
|
|
APOD
|
[NCBI]
|
1.201415e-07
|
|
|
C3
|
[NCBI]
|
1.086883e-07
|
|
|
CD36
|
[NCBI]
|
1.0464729e-07
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
9.57372e-08
|
|
|
GJB1
|
[NCBI]
|
8.48552e-08
|
|
|
PPSH
|
[NCBI]
|
8.2870823e-08
|
|
|
LOX
|
[NCBI]
|
7.42898e-08
|
|
|
LHCGR
|
[NCBI]
|
7.197948e-08
|
|
|
ANG
|
[NCBI]
|
7.06897e-08
|
|
|
HHF2
|
[NCBI]
|
6.40891e-08
|
|
|
SLC2A2
|
[NCBI]
|
4.08423e-08
|
|
|
CTNNB1
|
[NCBI]
|
3.05946e-08
|
|
|
pheochromocytoma
|
[NCBI]
|
1.54674e-08
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.109832e-08
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
6.09014e-09
|
|
|
LCA1
|
[NCBI]
|
6.09014e-09
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
5.20391e-09
|
|